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Korea predictive model for the estimation of agricultural operator exposure has 
been developed on the basis of new exposure data to improve the current 
agricultural operator exposure and risk assessment in the Korea. The new 
operator exposure model represents current application techniques (speed 
sprayer and power sprayer) and practices in representative crop fields (apple 
orchard and rice field). 30 replicate exposure studies conducted between 2010 
and 2012 were evaluated for the new model. Exposure and risk assessment were 
conducted for agricultural applicators during preparation of spray suspension 
and application with speed sprayer and power sprayer on crop fields. Several 
exposure matrices, including patches, cotton gloves, socks, masks and XAD-2 
resin were used to measure the potential exposure for workers. The analytical 
methods were fully validated to guarantee the precision and accuracy of 
analysis. As a major factor contributing to the exposure of operators, the 
amount of active ingredient used per day was identified. Other parameters such 
as formulation type, density of the canopy were selected as factors for sub-
scenarios. Accordingly, 75 percentile of exposure dose was calculated for 
mixing / loading and application according to scenario, and it was derived as 
exposure factor of Korean model. In vitro metabolism of kresoxim-methyl was 
conducted with human liver microsome. Two metabolites were identified. The 
screening test for identifying which recombinant CYP involved with 
metabolism of kresoxim-methyl was conducted with 10 human cDNA-
expressed CYP isoforms. Eight rCYPs (except 2A6, 2E1) contributed to 
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Chapter I 
Exposure of Operators using Patch Method, 





Occupational exposure study 
Pesticides have been used for the management of many insect pests, diseases, 
and weeds in agriculture for a long time. Agricultural workers would be 
exposed occupationally to pesticides during manufacture, mixing/loading, 
spraying, and harvest, while consumers could be exposed routinely by 
consumption of contaminated foods and drinks. In agriculture, the 
representative routes of exposure of pesticide applicators are dermal deposition 
and inhalation during pesticide application activities (Choi et al., 2006).  
From recent studies that assessed occupational exposure to pesticides, it 
was consistently demonstrated that 99% or more of total exposure occurred by 
the dermal route and 1% or less occurred via the respiratory route (Machado-
Neto, 2001). The most important variables that may affect occupational dermal 
exposure are the type of formulation and packaging, application technique, 
working method, and agricultural and climatic conditions (van Hemmen, 1992). 
Because pesticides are inherently toxic to living organisms, they are more likely 
to affect the health of humans than other agricultural chemicals (Tahir and 
Anwar, 2012). Therefore, it is positively necessary to quantify the occupational 
exposure to pesticides for safety evaluation of workers. 
Many exposure studies have been conducted for a workers, such as 
mixer/loader and applicator in a greenhouse, paddy field, and orchard, 
including apple, mandarin, and mango (Calumpang and Medina, 1996; Capri 
et al., 1999; Liu et al., 2003; Byoun et al., 2005a; Ramos et al., 2010; 
Baharuddin et al., 2011; Kim et al., 2012a; Kim et al., 2012b; Moon et al., 2013), 
estimating the deterministic exposure of individual workers to pesticide.  
２ 
 
Table 1. Some exposure studies of pesticide on crop (2000-2016) 
Pesticides Substance Dermal exposure Inhalation exposure Risk assessment Reference 
Spinosad Grape Whole body  -  - (Thouvenin et al., 2016) 
Flonicamid Apple Patches PAM XAD-2 - (Zhao et al., 2015) 
Deltamethrin 
Procymidone 
Tomato* Whole body - MOS (Ramos et al., 2010) 
Chlorpyrifos Cotton Patches 
PAM 
XAD-2 OVS tubes 
MOE (Farahat et al., 2010) 
 Pepper Patches - - (Nuyttens et al., 2009) 
Malathion Pepper Whole body - - (Machera et al., 2009) 
Deltamethrin Maize/Broccoli Whole body - MOS (Hughes et al., 2008b) 
３ 
 
Pesticides Substance Dermal exposure Inhalation exposure Risk assessment Reference 
Endosulfan Cotton Patches - another (Kuye et al., 2007) 
Captan Maize Whole body - MOS (Hughes et al., 2006) 
Cypermethrin Mandarin Patches PAM-XAD-2 MOS (Choi et al., 2006) 
Methidation Cucumber Patches PAM-XAD-2 MOS (Byoun et al., 2005b) 
Malathion Tomato Whole body PAM-XAD-2 - (MACHERA et al., 2003) 




Whole body - - (Vidal et al., 2002) 
４ 
 

























Methodology of agricultural worker exposure to pesticides 
Agricultural workers who mix/loads and spray pesticide in fields expose to 
pesticide through dermal and inhalation routes. In such situation, exposed 
amount should be measured quantitatively for reasonable risk assessment. 
Patch, gloves, socks and mask will be good materials for monitoring for dermal 
exposure while personal air monitor equipped with solid adsorbent and air 
pump will be a tool for inhalation exposure. For extrapolation of absorbed 
amount in dermal exposure matrices and of trapped amount in solid sorbent to 
total dermal or inhalation exposure, Korean standard body surface area and 
respiration rate were proposed in substitution of EPA data. Important exposure 
factors such as clothing and skin penetration ratio of dermal and inhalation 
exposure were suggested based on Spraying time for exposure monitoring must 
be long enough that the amount of pesticide to get absorbed/trapped in exposure 
matrices results in reasonable analytical value. In domestic case for the both of 
speed sprayer and power spray machine, spraying time of 20~40 minutes 
(0.1~0.2ha) will be reasonable per single replicate before extrapolating to 4 
hours a day with triplicates experiment.  
 
Dermal exposure 
Skin is an important route of exposure for materials at workplaces. It is clear 
that the behavioral component of exposure is very important, and that uptake 
of chemicals through the skin can exhibit high variability. Since the primary 
route of exposure in pesticide handlers is through the skin, most work in this 
field has focused on characterizing deposition of chemicals on the skin and their 
subsequent absorption into the body (Fenske and Day, 2005) 
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Dermal exposure is often divided into potential dermal exposure and actual 
dermal exposure. The definitions of these concepts vary in different sources. 
Whole body dosimetry, patch were mainly used to measure dermal exposure. 
In patch method, the potential contamination of the clothing is measured using 
a variable number of absorbent cloth or paper patches, attached to body regions 
inside or outside clothing (Durham and Wolfe, 1962). The surface area covered 
by the patches represents less than 10% of the total body surface area. After a 
defined or measured period of exposure, the patches are removed and analyzed 
for pesticide content. Body part surface areas can be obtained from standard 
reference texts and exposure guidance documents. The potential dermal 
exposure to pesticide sprays can be measured with the patch method (Durham 
and Wolfe, 1962; Davis, 1984; Gold and Holcslaw, 1985; Kurtz D and Bode 
W, 1985; Nigg H and Stamper J, 1985; Grover et al., 1986; Fenske et al., 1990; 
Fenske, 1993; Soutar et al., 2000; Liu et al., 2003; Kuye et al., 2007; Nuyttens 
et al., 2009; Farahat et al., 2010). The whole body method is an alternative to 
the patch method and allows measuring the body exposure over its whole 
surface area using dedicated cloth layers. The cloth layers mimic as well as 
possible the clothes people would normally wear during their work. Using this 
method, dermal exposure of the body and head (with a hood or a separate head 
cover or face/neck wipes) can be measured accurately. 
 
Risk assessment  
PDE, measured by analyzing the quantity of a pesticide that deposited on body 
regions, provides the information on the amount of exposure. But PDE data by 
itself cannot be used as a risk indicator because it must be related to acceptable 
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exposure limit. For this purpose, the MOS has been proposed as a useful risk 
indication (Machado-Neto, 2001) that relates the acceptable exposure to a 
pesticide with the mass absorbed by the body, which can be estimated from 
PDE. MOS value higher than 1 are considered as an indication of safe working 
condition. Durham and Wolfe (1962) derived the first equation to calculate the 
risk of intoxication from pesticides considering the toxicity and the exposure; 
residue/unit area of exposure pad surface is multiplied by a time factor, which 
is determined by the length of time the worker is exposed. In this equation, the 
risk was expressed in terms of percentage of toxic dose per hour (Davis, 1980).  
The MOS formula, proposed by Severn (1984), was the first equation to 
calculate the safety of work conditions for the agricultural handling of 
pesticides. Franklin (1985) proposed the following steps for risk assessment in 
the use of pesticides: obtain work exposure data and determine 
dermal/inhalation absorption correction, dosage estimation, NOEL from 
toxicological data, MOS or quantitative risk assessment, and acceptability of 
MOS. Work conditions, according to those risks, can be classified as safe or 
unsafe, considering the estimated MOS. In addition to the level of exposure 
incurred per hour of work, the hazard of pesticide exposure to workers was also 
related to the amount of time spent under these specified working conditions 
(Wolfe, 1976). However, risk characterization may have to proceed in the 
absence of an adequate or complete data set in many cases. In such 
circumstances, and when the adverse effect is considered to show a threshold 
in the dose-response relationship, additional uncertainty factors may be applied 
to the NOAEL (mg/kg body weight per day). The MOE is the ratio between the 
NOAEL and the estimated amount of human exposure. These approaches are 
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normally used when limited toxicological data or human data exist but the 
hazard identification and hazard characterization data are insufficient to set a 
health-based guidance value. Therefore, MOE is the ratio between the NOAEL 
in experimental or epidemiological studies, and the estimated amount of human 
exposure, while MOS is the ratio between the NOEL and the actual amount of 
human exposure (Renwick et al., 2003). Risk management / reduction is a major 
measurement if risk possibility was identified through risk assessment 
procedure. The determination of SWT and exposure control need ECN for 
unsafe work conditions (MOS < 1) can also be used in management strategies 
dealing with pesticide risks. The calculation of SWT can be used as a safety 
measure to control occupational exposure in pesticide use. The calculation of 
ECN permits the selection of a more appropriate safety measure, in regard to 
the needs of each set of working conditions (Machado-Neto, 2001).  
 
Predictive model  
Exposure estimates that are required for risk assessment may be obtained from 
chemical specific field studies, or from extrapolations from other field studies. 
This requires high quality exposure data that have been obtained under 
conditions relevant for the exposure and use scenarios under consideration. For 
risk assessment purposes, the exposure data obtained for relevant use scenarios 
can be compared with an appropriate accepted exposure level (Acceptable 
operator exposure level (AOEL)) based on the toxicological profiled of the 
compound. The generic approach to exposure assessment based on the 
grouping of uses into scenarios where activities are similar was presented by 
Franklin et al. (1982). This approach was further advanced by Hackathorn and 
Eberhart (1985), who discussed the development of a database for predictive 
9 
 
exposure modelling. The basic idea behind the development of such databases 
is that the level of exposure, when in a suitable format, can be extrapolated for 
similar-use scenarios. Currently, it is assumed that for mixing/loading, the main 
differentiation is for formulation type (i.e. between powders, granules, and 
liquids) used for hand-held application equipment, vehicle-mounted equipment. 
For application, the main differentiations used are upward or downward 
spraying and hand-held or vehicle-mounted spraying scenarios. Such databases 
contain field studies and exposure data extracted from those field studies in 
several formats (Kangas and Sihvonen, 1996). These studies are all different 
and most of them are not publicly available or critically reviewed in respect to 
documented criteria. The most important independent databases in use for risk 
assessment purposes in formal pesticide registration processes are PHED, the 
German model, UK-POEM, the Dutch model and EUROPOEM. These 
databases, also called predictive exposure models.  
The UK-POEM database is based on a review of the data available on the 
exposure of pesticide spray operators (in the UK). The review indicated that 
several factors determined the dose absorbed by a spray operator. These 
included the following: the volume of external contamination, the extent to 
which this external contamination penetrated clothing to reach the skin and the 
rate at which the chemical come into direct contact with the skin surface and 
was absorbed. These various independent factors were assumed, with the 
exception of dermal absorption, to be of a sufficient generic nature to be 
suitable for extrapolation purposes. Two major work activities were 
differentiated: mixing/loading and application. An updated of the default values 
in UK-POEM has been presented (POEM, 1992) or mixing/loading, two 
formulation types are considered, namely liquids and powders. The database is 
largest for liquids and the level of exposure is shown to be largely dependent 
10 
 
on the container size and the neck aperture. A default value for the 75th 
percentile was based on test data on pouring. The current risk assessment for 
pesticide operators is based on the comparison of a reliable exposure estimate 
with the respective AOEL normally derived from subacute or subchronic 
toxicological studies. The use of a plant protection product is considered safe 
when the exposure estimate calculated for daily systemic exposure is below the 
AOEL. UK POEM is deterministic models that rely on empirical data from 
exposure studies conducted before 1990 and allow exposure predictions for 
mixing/loading and application. Exposure in the models largely depends on the 
total amount of active substance used, the duration of exposure or the container 
size and number of mixing/loading tasks. Moreover, the formulation type and 
the spray equipment are important factors, too. In the UK-POEM professional 
operators are assumed to wear work clothes that cover the whole body and are 
permeable for a certain fraction of the contaminating pesticides. Additional 
protective equipment for the operators (e.g. protective gloves) can be chosen in 
model in order to reduce the exposure prediction (Großkopf et al., 2013). 
The models are based on a limited number of studies and are not validated. 
Thus, the models may not always be sufficiently representative for Korea 
conditions. The limitations of model estimates of exposure are taken into 
consideration when the calculated level of exposure is close to the threshold 
limit for AOEL.  
Korea Predictive Operator Exposure Model 
A new model for prediction of exposure of professional operators applying 
plant protection products outdoors has been developed using previously 
unpublished field data collected between 2011 and 2012. It provides calculati- 
ions for estimating the exposure for typical scenarios including the mixing/ 
11 
 
loading and the application of plant protection products. The underlying 
equations are based on log linear models for prediction of the 75th percentile 
and consist of exposure factors that were selected after a statistical analysis. 
The exposure mainly depends on the total amount of active substance used per 
day and is further described by additional factors or particular sub-scenarios. 
The model allows a tiered approach starting with estimating exposure for an 
operator wearing at least one layer of clothing; risk mitigation by using personal 
protective equipment can be considered if the AOEL is exceeded. The model 
reflects current application techniques and typical work conditions in Korea. It 
is, therefore, applicable for registrations of plant protection products in Korea. 






















Part 1  
 
Probabilistic Exposure Assessment for Applicators 
during Treatment of the Fungicide Kresoxim-








The deterministic approach (point estimation) is very simple method to estimate 
the exposure and completely lacking in uncertainty quantification (WHO, 
2008). The deterministic exposure assessment could not be sufficient for risk 
management decision because the levels of pesticide exposure for applicator 
could be fluctuated widely by different agricultural conditions, even if same 
person apply the pesticide suspension on the same kinds of crops. For 
substances requiring further refinement beyond point estimates of exposure, a 
probabilistic (stochastic) analysis of exposure variability can be conducted 
(WHO, 2008). Probabilistic approach is conducted by combining frequency 
distributions that the variable will take any specific value in the range of values 
and can quantify uncertainties (Gilsenan et al., 2003). Therefore, worker 
exposure must be thought of a range of values, rather than a single value, 
because individual of worker population have different levels of exposure. 
Kresoxim-methyl is a strobilurin fungicide which has been used for the control 
of scab (Venturia spp.) and powdery mildew (Podosphaera leucotricha) in 
apples, mandarin, grape and pears. It has an inhibition activity against spore 
germination with long residual effect. It is poorly soluble in water (solubility: 
2 mg/L), and is relatively stable at pH 5. Toxicity to mammalian is low as acute 
oral LD50 for rat is >5,000 mg/kg, and acceptable daily intake (ADI) value is 
0.4 mg/kg b.w./day (Tomlin, 2009). To the best of our knowledge, there are no 
previously published studies on probabilistic exposure assessment for workers 
during application of kresoxim-methyl. The present study was carried out to 
estimate probabilistic exposure by Monte-Carlo simulation when kresoxim-
methyl was applied in apple orchard using speed sprayer by thirty replicates. 
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Major exposure characteristics were identified and related risk assessment was 









Materials and Methods  
Reagents and materials 
Kresoxim-methyl water-dispersible granule formulation (Haevichi, WG, 50%, 
Sungbo Chemical, Seoul, Korea) was obtained through the local vendor. 
Analytical standard of kresoxim-methyl (purity, 97.8%) was purchased from 
the ChemService Inc. (West chester, PA). All solvents were HPLC grade, and 
purchased from Burdick & Jackson (SK Chemical, Ulsan, Korea).  
 
Dermal exposure matrices 
Patches made by putting cellulose TLC (Thin-layer chromatography) paper 
(17CHR, 1 mm thickness, Whatman International Ltd., UK) in the patch pocket 
(10 cm × 10 cm). The area of the circular exposure part on the patch was 50 
cm2. The back of the TLC paper in a patch was covered with aluminum foil to 
prevent contamination (Kim et al., 2012b). Cotton gloves, socks and square 
cotton mask were used for hand, feet and face exposure measurement, 
respectively (Kim et al., 2011). The area of square cotton mask was 200 cm2.  
 
Inhalation exposure matrices 
For inhalation exposure measurement, a personal air monitor equipped with air 
pump (GilAir-3, Sensidyne, Clearwater, FL), solid sorbent tube (ORBOTM 609 
Amberlite XAD-2 400/200 mg, Supelco, Bellefonte, PA) and glass fiber filter 
(Type AE, SKC, Eighty four, PA) in 37 mm open-faced cassettes were used 
(Kim et al., 2012b; Kim et al., 2013; Moon et al., 2013). The solid sorbent tube 
consisted of one larger bed of absorbent (400 mg) followed by a smaller back-




Experimental sites and field trials  
The field studies were conducted in apple field (Gunwi-myeon, Gyeongbuk, 
Korea). The temperature and relative humidity were monitored with a 
thermometer and a hygrometer at the start and end of the mixing / loading or 
spraying activity, respectively. Wind speed was measured using a pocket 
weather meters (Kestrel 3000, Nielsen-Kellerman, Boothwyn, PA) (Table 2). 
Before mixing/loading or application, all workers wore protective garments (SP 
protective, KleenGuard, Yuhan-Kimberly Korea Ltd, Seoul, Korea). Workers 
made spray suspension for 9~18 min by mixing Haevichi WG 50% (167 g, 1 
pack) with 500 L water in mixing tank and sprayed two tanks of 500 L spray 
suspension with speed sprayer (Model TLD ASS-555, Asia Motors, Daegu, 
Korea) for 24~48 min on 0.2 ha. Each replicate consisted of two 500L 















Table 2. Field characteristics, application and meteorological conditions in 
apple orchard 
Field  Application  
application area (ha) 0.20‒0.33 application method 
speed 
sprayer 
age of plants (years) 3‒35 number of nozzle 25‒29 
plant growth stage 
fruiting 
stage 
boom length (m) 4‒12 
planting density dense climate  
plant height (cm) 350‒500 temperature (oC) 15‒31 
inner row distance (cm) 100‒500 relative humidity (%) 22‒82 





Exposure matrices sampling  
During mixing/loading, workers wore only gloves. In application, dermal 
patches were placed on the outer protective garment, over forehead, front of 
neck, back of neck, chest/abdomen, back, upper arms, forearms, thighs and 
shins of workers. Applicators wore cotton gloves, cotton socks and masks. A 
glass fiber filter cassette and a XAD-2 resin tube were attached with clips on 
breathing zone of worker, and air pump was fastened on the belt. The air flow 
rate was 1 L/min. After mixing/loading or spraying, exposure samples were 
collected by preventing contamination. 
 
Extraction of kresoxim-methyl from exposure matrices 
Kresoxim-methyl on patches, gloves, socks and mask were extracted with 50 
or 300 mL of methanol in a 100 or 500 mL glass bottle by shaking at 200 rpm 
for 1 h in a shaker (Wooju Scientific, Gimpo, Korea). After 1‒2 mL of the 
extract were filtered through a 0.2 μm pore syringe filter (4 mm, Milipore, 
Billerica, MA), aliquots were analyzed with high performance liquid 
chromatography (HPLC). The pesticide trapped on XAD-2 resin and filter was 
extracted using 10 mL of methanol in a 20 mL vial and concentrated 10 times 




Kresoxim-methyl residues were determined with HPLC (Agilent 1100 series, 
Agilent Technologies Inc., Santa Clara, CA) with an automatic injector. Patch 
extract was analyzed with a Luna C18 column (5 μm particle size, 4.6×250 mm, 
21 
 
Phenomenex, Torrance, CA) using the mixture of acetonitrile : water = 80 : 20 
(v/v) as mobile phase. Meanwhile, for analysis of gloves, socks, mask, XAD-2 
and filter samples, gradient elution and a ZORBAX Eclipse XDB-C18 column 
(5 μm particle size, 4.6 x 250 mm, Agilent Technologies Inc., Santa Clara, CA) 
was used due to more complex matrix. The mobile phase in a gradient system 
was programmed as follows: 20% acetonitrile at initial time, increased to 50% 
acetonitrile for 10 min, held for 20 min, increased to 80% acetonitrile for 1 min, 
and held for 4 min. The flow rate was 1.0 mL/min and injection volume was 20 
μL. A diode array detector (Agilent Technologies Inc., Santa Clara, CA) was 
used for detection at 220 nm. 
 
Method validation 
Aliquots of standard solutions from 0.001 to 1 mg/L were analyzed for 
determination of instrumental limits of detection (ILODs) and instrumental 
limits of quantitation (ILOQs). The method limits of quantitation (MLOQs) 
were calculated from ILOQs, injection volume and extract solvent volume in 
analytical method. After injecting three levels (MLOQ, 10MLOQ and 100 
MLOQ) of standard solution 7 times, C.V. values of the integrated peak area 
was determined to validate instrumental repeatability. Various standard 
solutions (LOQ level) were analyzed and the linearity of the curve was 
investigated after one day and three days of preparation. For recovery test, 
control exposure samples were fortified in three levels (MLOQ, 10 MLOQ and 
100 MLOQ) of standard solution. The trapping efficiency was tested by spiking 
two levels of standard solution (10 MLOQ and 100 MLOQ) on the bottom of 
U-shape glass tube (Daejung Chemical, Daejeon, Korea) connected with solid 
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sorbent, and passing air through the system at 1 L/min for 4 h. U-shape glass 
tube was heated to 70oC to help volatilization of compounds. The residue in U-
shape glass tube and the amount trapped in XAD-2 resin were analyzed for 
mass balance. Breakthrough test was conducted by spiking two levels of 
standard solution (10 MLOQ and 100 MLOQ) in the 1o-resin part of the solid 
sorbent tube and passing air through the tube at 1 L/min for 4 h. Subsequently, 
1o- and 2o-part of resin were analyzed separately. All analysis and test were 
repeated 3 times. 
 
Exposure assessment 
Dermal exposure amount (μg) per body part was determined by extrapolating 
kresoxim-methyl residue (μg) on a dermal exposure matrix to the ratio of the 
area of the matrix to the body surface area (cm2) for adult Korean (Kim et al., 
2011). Inhalation exposure amount (ng) was obtained by extrapolating pesticide 
residue (ng) in an inhalation exposure matrix to the ratio of the air volume 
collected to the respiration rate of working situation (1,270 L/h) for adult male 
Korean (Kim et al., 2011). The PDE and PIE per day were determined by 
multiplying the corresponding exposure amount with ten working activities 
(mix/loading and application using speed sprayer). The ADE for mixer/loader 
and applicator was calculated from PDE based on 1% and 10% the penetration 
rate through clothes (Kim et al., 2011) and 0.3% (neat formulation) and 13% 
(spray mix) skin absorption (European Food Safety, 2010), respectively. The 
AQE (mg/day) value was determined by adding up of ADE and PIE on the 
assumption of 100% absorption through inhalation (Oliveira and Machado-
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Neto, 2003; Fenske and Day, 2005; Kim et al., 2012b). The AQE per unit body 
weight was obtained by dividing AQE by body weight.  
 
Exposure estimation using Monte Carlo simulation 
Pesticide exposure (AQE per body weight) was modeled as: 
AQE per body weight =
 {∑ (𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑑𝑑𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑑𝑑𝑑𝑑)𝑖𝑖×(𝑒𝑒𝑑𝑑𝑝𝑝𝑑𝑑𝑝𝑝𝑑𝑑𝑑𝑑𝑝𝑝𝑝𝑝𝑒𝑒𝑝𝑝 𝑑𝑑𝑑𝑑𝑝𝑝𝑑𝑑)𝑖𝑖×(𝑒𝑒𝑠𝑠𝑝𝑝𝑝𝑝 𝑑𝑑𝑎𝑎𝑒𝑒𝑒𝑒𝑑𝑑𝑒𝑒𝑝𝑝𝑝𝑝𝑒𝑒𝑝𝑝 𝑑𝑑𝑑𝑑𝑝𝑝𝑑𝑑)𝑖𝑖𝑖𝑖 }+𝑝𝑝𝑝𝑝ℎ𝑑𝑑𝑑𝑑𝑑𝑑𝑝𝑝𝑝𝑝𝑒𝑒𝑝𝑝 𝑑𝑑𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑑𝑑𝑑𝑑
𝐵𝐵𝑒𝑒𝑑𝑑𝐵𝐵 𝑤𝑤𝑑𝑑𝑝𝑝𝑤𝑤ℎ𝑝𝑝
× 10 
Where, dermal exposure for each body part i, inhalation exposure and body 
weight are randomly selected from input distributions. Dermal and inhalation 
exposure were fitted with the best distribution to describe the distribution of 
exposure per body part. Akaike Information Criterion (AIC) was used to choose 
the best fitted distribution. The quality and stability of the reported parameters 
and statistics for the best fitted distribution was proved by the method of 
parametric bootstrap. We made an a priori determination to represent body 
weight for adult male Korean (mean 70.5 kg b.w., 95%CI 51.2‒94.7 kg b.w.) 
as empirical cumulative distribution, because this distribution was considered 
the most representative description of the data of the large sample size. The 
forecasts, including PDE, PIE, ADE, ADE and AQE were determined by 
performing Monte Carlo simulations using probability distribution functions of 
body parts exposure. Monte Carlo simulations were conducted with Latin 
Hypercube sampling. After exposure estimation using Monte Carlo simulations, 
sensitivity analysis was conducted to look at which input distributions have the 
greatest effect on the eventual distribution. For checking the output 
reproducibility by simulations, the variance of forecasts for AQE per unit body 
weight was calculated by repeating each simulation three times with different 
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number of iterations. Fitting distributions to data and Monte Carlo simulations 
were conducted using @RISK (Palisade Corporation, Ithaca, NY, USA).  
 
Risk assessment 
The risk assessment was carried out by comparing the pesticide exposure 
forecasted to the relevant risk value, AOEL. For this, the margin of safety 
(MOS) for workers was calculated using following modified formula: MOS = 
AOEL / AQE per unit body weight. AOEL of kresoxim-methyl is 0.9 mg/kg 






Results and discussion 
Selection of crops and pesticide 
Apple, one of the most produced and consumed fruits in Korea, was selected to 
represent orchard because the cultivated area and yield of apple was 30,449 ha 
(18.9% of fruits) and 493,701 tons (19.6% of fruits) in 2013, respectively. In 
orchard, 64.9% of farmers prefer to use speed sprayers than power sprayers for 
the application of pesticides (Hong et al., 2007). Kresoxim-methyl was selected 
for this study because this pesticide was applied on more than 60% of apple 
farms in Korea. 
 
Method validation 
ILOQ was defined as 1.0 ng, 5 times greater than ILOD, 0.2 ng (signal-to-ratio 
of >3). MLOQs of exposure matrices were determined as 2.5, 15, 15, 15 and 
0.05 μg for patches, gloves, socks, mask and XAD-2 resin, respectively. These 
values were low enough to quantify the trace level of kresoxim-methyl in 
exposure matrices. Good instrumental repeatability (C.V. < 8%) and consistent 
linearity of calibration curves for 3 days (R2 >0.999) showed the analytical 
instrument was precise and stable (Table 3). Recovery from various matrices 
were ranged from 71.2 to 119.5% (C.V. = 1.3‒10.7%) (Fig. 1), providing the 
extraction efficiencies are reliable. In trapping efficiency test, mass balance (> 
90%) was good and the most of kresoxim-methyl remained in XAD-2 resin 
(Table 4). Kresoxim-methyl was retained more than 90% on the first part of the 
XAD-2 resin in the breakthrough test, indicating that the first resin part 
possessed a suitable holding capacity (Table 4). Therefore, XAD-2 resin was 
useful for trapping and holding kresoxim-methyl in air, as successfully applied 
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for other pesticides (Kim et al., 2012b). In short, all analytical and sampling 
methods were well validated according to above results.  
 
Determination of the number of iterations 
The output stability from simulation to simulation was an especially important 
for the precision of forecasts. The variance of the mean and high-end 95th 
percentile forecasts of AQE per unit body weight was calculated by repeating 
each simulation three times with 100, 500, 1,000, 5,000 and 10,000 iterations. 
Because the high-end forecasts consistently stabilized at <0.5% variance when 
the number of iterations was more than 10,000 iterations, 10,000 iterations were 







Table 3. Instrumental repeatability and linearity of calibration curve 
Instrumental repeatability 
Levels Average (area) C.V. (%) 
ILOQ 4.7 7.7 
10 ILOQ 37.6 1.3 
100 ILOQ 374.3 0.4 
Linearity (R2) 
Day of preparation 0.999 
After 1 day 0.999 








































































Figure 2. Variability in AQE per unit body weight as simulation estimates 







































Table 4. Breakthrough and trapping efficiency of XAD-2 resin 
Tests treated level recovery (%, mean±standard deviation) 
breakthrough 
 1o-XAD 2o-XAD 
10 MLOQ 94.4±6.5 13.4±10.8 
100 MLOQ 110.4±5.7 23.6±14.0 
trapping 
efficiency 
 residue XAD Total 
10 MLOQ 11.0±0.3 84.5±1.8 95.5±1.6 
100 MLOQ 12.6.0±0.2 88.0±0.8 100.6±1.0 





Dermal exposure assessment 
The dermal exposure during mixing/loading was measured on only hands as 
suggested by national guidelines. Because the hands were reported to be 
significantly more exposed than other body parts and occupied 19~100% of the 
total dermal exposure for mixer/loader (Machera et al., 2002b; Kim et al., 
2012b; Choi et al., 2013; Moon et al., 2013; Choi and Kim, 2014). The hand 
exposure to kresoxim-methyl for mixer/loader was 0.7 mg (95%CI 0.02‒2.4) 
(Table 8), taking 0.0005% (95%CI 1.2×10-5‒0.001) of total prepared active 
ingredient (a.i.). This ratio of dermal exposure was less than 0.0007~0.59% 
reported in the previous studies (Kim et al., 2012a; Kim et al., 2012b; Choi et 
al., 2013; Kim et al., 2013; Moon et al., 2013; Choi and Kim, 2014), because 
WG formulation used in this study is larger and heavier than WP and is less 
absorbed into cotton glove than EC or SL.  
During application of kresoxim-methyl, the amount of dermal exposure was 
17.5 mg (95%CI 9.3‒28.9), corresponding to 0.010% (95%CI 0.006‒0.017) of 
total applied a.i. (Table 8), being within the range of 0.003~0.048% on apple 
orchard as reported in previous studies (Kim et al., 2012b; Kim et al., 2013; 
Moon et al., 2013). The results of sensitive analysis showed that thighs and 
shins, each with correlation coefficients of 0.53 and 0.43, respectively, had the 
greatest influence on the dermal exposure during application, followed by 
chest/abdomen and upper arms showed correlation coefficient 0.33 and 0.30, 
respectively (Fig. 3). Similar tendency was also observed during application of 
acetamiprid, fenvalerate and methomyl with SS (Kim et al., 2012b; Kim et al., 
2013; Moon et al., 2013). Whereas the hands was reported to be the major 
exposed parts if the power sprayer was used on apple orchard (Machera et al., 
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2002b; Choi et al., 2013; Choi and Kim, 2014), hands for applicator using SS 
was exposed less than chest and arms. 
 
Inhalation exposure assessment 
The inhalation exposure during application was estimated as 6.8 ng (95%CI 
0.4‒17.0) from Triang distribution. The ratio of inhalation exposure to dermal 
exposure was 0.04%, being less than 0.1% of dermal exposure as observed in 
other studies (Kim et al., 2012b; Moon et al., 2013). 
 
Exposure database for predictive model  








Table 5. Dermal exposure per hour of kresoxim-methyl (mL/h)  
Trials 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Head 24.7  9.1  3.6  7.2  11.8  4.4  8.1  19.4  7.6  4.5  4.3  17.3  12.2  3.4  20.3  
Neck of front 5.4  0.5  0.3  0.6  0.4  0.2  1.1  1.0  1.8  0.7  0.6  2.1  1.3  0.4  2.3  
Neck of back 4.0  1.4  1.4  1.0  1.7  0.7  1.3  2.8  0.9  0.8  0.5  4.6  1.5  3.1  2.3  
Chest 31.0  9.0  2.2  6.4  10.9  0.2  3.9  9.9  9.9  2.2  5.0  38.1  27.7  27.3  47.2  
Back 14.4  5.8  1.2  3.7  2.9  0.7  2.7  3.8  2.2  3.5  4.0  16.5  16.9  19.7  10.8  
Upper arm(L) 10.8  2.3  0.8  1.3  2.1  0.5  2.2  13.3  9.0  2.2  2.2  9.2  10.6  16.2  8.9  
Upper arm(R) 51.8  10.2  10.0  12.3  12.5  2.0  11.1  28.8  8.4  4.8  1.3  58.0  9.1  10.9  14.4  
Forearm(L) 6.9  1.8  0.9  0.8  1.6  0.5  1.1  6.3  1.8  0.3  1.1  8.9  11.1  9.6  7.0  
Forearm(R) 8.6  0.2  0.6  2.8  9.3  0.3  6.9  14.1  3.8  0.8  0.3  4.9  3.8  6.0  5.2  
Thigh(L) 20.6  8.2  7.7  10.1  12.0  2.3  7.7  20.2  9.3  6.7  4.7  18.3  20.6  41.9  22.2  
Thigh(R) 59.1  17.4  18.2  18.0  20.8  5.0  20.7  43.6  16.9  8.5  3.0  18.8  21.5  44.0  34.4  
Shin(L) 24.5  13.6  6.2  3.7  8.8  4.4  7.4  10.6  10.1  3.2  5.7  27.9  25.9  19.0  14.6  
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Shin(R) 36.3  10.6  8.9  7.4  8.1  4.4  11.1  24.8  6.5  5.0  2.9  18.1  8.3  11.1  11.2  
Face 5.5  0.7  0.6  1.4  0.9  0.8  1.3  2.6  2.8  2.7  0.5  1.0  0.7  1.3  1.0  
Hands 14.8  2.9  2.4  3.2  4.1  1.5  1.4  0.8  14.2  1.3  14.6  1.0  28.6  3.8  2.8  
Feet 6.2  1.0  0.5  1.2  1.5  0.6  2.5  2.8  2.7  8.9  1.3  4.9  2.6  5.2  3.9  





Table 5. Continued 
Trials 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
Head 54.5  7.0  29.2  13.2  21.3  19.4  28.9  14.0  29.2  15.7  21.9  2.6  2.7  38.2  23.8  
Neck of front 8.8  5.9  6.8  3.6  3.4  0.7  5.4  0.7  1.5  1.8  2.3  0.8  0.6  4.1  2.4  
Neck of back 8.4  4.8  3.5  2.1  1.5  1.3  4.1  2.2  2.7  1.9  2.3  1.6  1.1  4.0  1.3  
Chest 129.9  24.5  4.1  17.8  21.7  25.0  18.7  15.0  10.2  2.5  29.4  23.9  15.2  13.9  26.2  
Back 88.9  5.2  6.9  42.4  6.1  4.4  10.7  15.7  2.3  2.2  26.2  18.1  4.6  10.2  18.3  
Upper arm(L) 13.5  3.3  30.1  1.8  8.0  1.4  10.7  4.7  2.2  2.1  6.0  4.2  3.9  11.0  14.2  
Upper arm(R) 17.2  26.2  20.8  2.7  20.1  24.3  7.5  5.3  24.0  19.9  29.2  8.1  3.0  5.4  30.2  
Forearm(L) 23.0  6.0  3.4  2.2  11.8  11.2  5.3  3.6  2.2  2.2  5.4  2.9  1.4  24.3  14.7  
Forearm(R) 29.3  24.2  19.2  1.4  19.3  9.6  12.0  0.9  5.4  2.5  16.9  2.5  2.0  5.3  15.8  
Thigh(L) 70.8  31.0  25.5  11.3  35.5  17.7  20.8  22.8  19.5  14.3  25.0  20.3  19.8  34.2  57.4  
Thigh(R) 44.0  63.0  60.4  11.6  32.4  26.8  17.4  43.8  49.4  21.9  37.5  16.6  15.7  67.4  50.6  
Shin(L) 96.6  49.3  44.3  14.9  16.6  0.5  3.7  11.5  20.6  13.2  15.7  7.7  10.9  16.1  13.3  
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Shin(R) 76.2  66.5  55.5  15.7  12.4  2.9  45.1  16.2  11.8  14.2  19.3  12.8  2.5  25.7  20.6  
Face 6.6  4.5  2.9  2.9  3.1  2.2  2.8  0.9  1.5  0.6  2.5  0.7  1.0  1.5  1.4  
Hands 7.5  6.7  1.0  14.8  21.3  28.9  19.8  6.2  5.2  15.5  4.9  1.4  26.0  27.0  0.9  
Feet 3.9  3.2  2.1  2.4  2.4  3.4  2.4  2.4  2.4  0.2  2.1  2.2  2.5  2.9  4.1  





Because it takes average 48 min for preparation and application of 1,000L 
(500L x 2) spray suspension, workers could conduct about ten working 
activities with speed sprayer for 8 h per day. The reliable exposure estimates 
were determined from dermal and inhalation exposure amount on several 
assumptions, including day-to-day activity, penetration rate through clothes, 
skin absorption and body weight for adult male Korean (Table 14). The AQEs 
were 2.1×10-4 mg/day (95%CI 5.0×10-6‒7.2×10-4) and 2.3 mg/day (95%CI 
1.2‒3.8) for mixer/loader and applicator, respectively. The 95th percentile 
AQEs for mixer/loader and applicator were 7.2×10-4 and 3.4 mg/day, which 
were higher 1.5‒3.4 times than average AQEs, respectively. The ratio of PIE to 
AQE during application was 0.003% (95%CI 0.0003‒0.004%), so inhalation 
exposure was negligible as the other study (PIE 0.02‒0.06 μg/day) with 
acetamiprid (Kim et al., 2013). The ADE during application was similar to the 
study with methomyl (1.1‒2.0 mg/day) and higher 3‒12 times than the study 
with acetamiprid (0.8 mg/day) and fenvalerate (0.2‒0.4 mg/day) (Kim et al., 
2012b; Kim et al., 2013; Moon et al., 2013). Meanwhile, the AQE during 
mixing/ loading was 0.009% of that during application. The predicted 
distribution of MOS for kresoxim-methyl was 30.4 (95%CI 15.4‒55.2) (Table 
5, Figure 4). The proportion of the general Korean workers under the threshold 
for concern (MOS <1) was almost zero, indicating workers using SS on apple 
orchard are considered to be safe from kresoxim-methyl exposure. This was 
due to low toxicity (AOEL, 0.9 mg/kg) and low skin absorption rate (13%) of 
kresoxim-methyl, despite high exposure occurrence and high a.i. content of 













































Table 6. Dermal exposure on body parts during mixing/loading and 
application 
body parts 
Dermal exposure (mg) 
Best fitted 
distribution 
Average 95%CIa  
mixing Hands 0.7 0.02‒2.4 Expon 
application 
Head 1.4 0.2‒4.0 Gamma 
Face 0.2 0.04‒0.5 Invgauss 
front of neck 0.2 0.02‒0.8 Invgauss 
back of neck 0.2 0.06‒0.6 Invgauss 
chest/abdomen 1.8 0.04‒6.5 Expon 
Back 1.0 0.1‒4.5 Lognorm 
upper arms 2.2 0.2‒5.2 Triang 
Forearms 1.2 0.03‒4.5 Expon 
Thighs 4.9 0.9‒10.2 Triang 
Shins 3.3 0.5‒11.0 Loglogistic 
Hands 0.8 0.1‒3.8 Invgauss 
Foot 0.3 0.05‒0.9 Loglogistic 
Total 17.5 9.3‒28.9  




Table 7. Probabilistic risk estimation during mixing/loading and 
application of kresoxim-methyl on apple orcharda 































aPDE: potential dermal exposure, ADE: actual dermal exposure, PIE: potential 
inhalation exposure, AQE: absorbable quantity of exposure, MOS: margin of 
safety. 
b,dPDE and PIE were calculated on assumption of working number: 
mixing/loading and application are conducted 10 times a day with SS. 
cADE = [PDE × 1% (mix/loading) or 10% (application) of penetration rate 
through clothes] × 0.3% (mix/loading) or 13% (application) of skin 
absorption. 
















Exposure and Risk Assessment of Operators to 








Apple is one of the most produced and consumed fruits in Korea. The cultivated 
area and amount of production is 31,167 ha and 379,541 ton in 2011, 
respectively (KOSIS, 2011). Pesticides are indispensable chemicals that are 
widely used to control insects, diseases and weeds in agricultural field, and 165 
pesticides were registered for apple (KFDA, 2012). Thus operator, who handle 
and apply pesticides in fields, can be exposed to pesticides during 
mixing/loading and spraying in apple orchard. Safety and health of operator 
during mixing/loading and application is a major concern in agricultural 
activities (Ramos et al., 2010) because direct contact with pesticides by 
operators who handle and apply these agents can lead to harmful effects 
depending on the toxicity of pesticides. In orchard, 64.6% of famers prefer to 
use speed sprayer than power sprayer for the application of pesticides (Hong et 
al., 2007). They wear long-sleeve shirts and long trouser instead of protective 
garments while spraying. Therefore there could be significant dermal exposure 
to operators to results in the unintended field-poisoning. During spraying, the 
representative routes of human exposure are dermal deposition and inhalation 
(Kim et al., 2012). Potential dermal exposure (PDE), measured by analyzing 
the quantity of a pesticide that deposited on body regions, provides the 
information on the amount of exposure. But PDE data by itself cannot be used 
as a risk indicator because it must be related to acceptable exposure limit. For 
this purpose, the margin of safety (MOS) has been proposed as a useful risk 
indication (Machado-Neto, 2001) that relates the acceptable exposure to a 
pesticide with the mass absorbed by the body, which can be estimated from 
PDE. MOS value higher than 1 are considered as an indication of safe working 
condition. Acetamiprid is a systemic neonicotinoid insecticide which is 
intended to control sucking insects on crops such as leafy vegetables, citrus 
fruits, pome fruits, grapes, cotton, and ornamental plants. It has a low acute and 
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chronic toxicity in mammals with no evidence of carcinogenicity, neurotoxicity 
endocrine disruption or mutagenicity (Marı́n et al., 2004). However, there is no 
previous exposure and risk assessment of operator to insecticide acetamiprid in 
apple orchard, to our knowledge. Thus, in this study, dermal and inhalation 
exposure amounts were measured during mixing/loading and application of 
acetamiprid after analytical methods were fully validated. Body parts of major 
exposure were identified and MOS for operator was calculated based on PDE 




Materials and Methods  
 
Reagents and materials 
Acetamiprid (99.9%) of analytical standard grade was purchased from Sigma-
Aldrich (MO, USA). All solvents were HPLC-grade, and were purchased from 
Fisher Scientific Korea Ltd (Ansung, Korea). Stock solution (100 μg/mL) was 
prepared HPLC-grade acetonitrile. The working standard solutions were 
prepared by serial dilution of stock solution in acetonitrile. Acetamiprid 
wettable powder (WP) (8%) was purchased from pesticide vender for field 
study.  
 
Exposure matrices  
Dermal patches for dermal exposure measurement were made by putting 
cellulose  paper (Whatman 17CHR, 46 × 57 cm, 1 mm thickness; Kent, UK) 
in the patch pocket (10 cm × 10 cm), which has circular exposure part (50 cm2). 
Safety pins were used to attach patches on protective garment (SP protective, 
KleenGuard, Yuhan-kimberly Korea Ltd, Seoul, Korea) of operator. Cotton 
mask (face exposure; 200 cm2), cotton socks (feet exposure), cotton gloves 
(hands exposure) were purchased from local markets. A personal air monitor 
(PAM) consists of air pump (Gillian Model 224-PCXR7, MSA, Dong Ha 
Trading Co. Ltd, Seoul, Korea), glass fiber filter (37 mm, SKC, Eighty Four, 
PA) in open-faced cassette (SKC) and solid sorbent (ORBOTM 609 Amberlite 
XAD-2 400/200 mg, Supelco, MO, USA). U-shape glass tube for trapping 





All the field studies were carried out in apple research institute orchards (Table 
8). The unit size of site for repetition was 0.2 ha. The apple crop height was 2.5 
and 5 m, and rows were separated by 4-6 m. During the experiment, ambient 
temperature was 9-24 oC and relative humidity was 16-61%. Wind velocity did 
not exceed 4 m/s (Kester 3000, Nielsen-Kellerma, USA). 
 
Chromatographic condition 
All chromatographic analysis were performed on a High Performance Liquid 
Chromatograph (Agilent 1100 HPLC; CA, USA) with automatic injector, DAD 
(diode array detector), and a Shiseido C18 column (250 mm × 4.6 mm, 5 μm 
particle; Kyoto, Japan) at 40 oC. The mobile phases A and B were water and 
acetonitrile, respectively. A gradient system was employed for 15 min at the 
flow rate of 1.0 mL/min with A:B as follows: initial 0 min, 50:50; 1 min, 50:50; 
10 min 30:70; 10.5 min 0:100; 12 min, 0:100; final 15 min 50:50. Injection 





Table 8. Field conditions, application data, and meteorological conditions 
of operators of acetamiprid 
Applicator Op. 1 Op. 2 Op. 3 Op. 4 
 Applicator 
Years of experience  20 20 25 30 
Repetition, 8 9 4 7 
Sex male male male male 
Height (cm) 172 173 165 175 
Weight (kg) 65 60 65 68 
Field 
Area (ha) 0.2 0.2 0.2 0.2 
Crop age (years) 4-30 3-35 3-26 5-25 
Crop growth stage Before blossom stage     
Crop height (m) 3-4 3.5 2.5-4 3-4 
Inner row crop distance 
(m) 
0.5-1 1-2 1-3 1-4 
Row distance (m) 4-5 4 4-6 4-6 
Pesticide 
AI content used (g) 40 
Spray volume (L) 1,000 
Application 
Type of spray application Speed sprayer 
Boom length (m) 10 8 8 7 
Application time (min) 35-45 40-45 35-40 35-45 
Nozzle size Small Small Small Small 
Climate    
Temperature (℃) 10-24 9-21 7-20 9-24 
Relative humidity (%) 22-54 21-61 16-62 19-50 








Limit of detection (LOD), limit of quantitation (LOQ), reproducibility and 
linearity of calibration curve  
Aliquots (10 μL) of acetamiprid standard solution (0.01~1.0 μg/mL) were 
analyzed for LOD determination before LOQ calculation. For reproducibility 
test, three levels (LOQ, 10 LOQ, and 50 LOQ) of acetamiprid standard solution 
were analyzed six times by HPLC to calculate coefficient of variation (C.V). 
Various acetamiprid standard solutions (0.1-10 μg/mL) were analyzed for 
establishment of calibration curve. After 1 and 3 days of storage, the linearity 
(coefficient determination, R2) of the curve was investigated again 
 
Trapping efficiency and breakthrough tests  
Trapping efficiency test was repeated three times by spiking of a standard 
solution (10 LOQ) on the bottom of U-shape glass tube connected with solid 
sorbent, and air was passed through the system at 60 L/h for 4 h for trapping of 
vaporized acetamiprid. To help the volatilization of compounds, U-shape glass 
tube was heated to 70℃. The residue in U-shape glass tube and the amount 
trapped in solid sorbent were analyzed for mass balance. 
For breakthrough test, acetamiprid at 10 LOQ level was spiked in the first 
part before passing air through the solid sorbent at 60 L/h for 4 h. Subsequently, 
first part and second part were analyzed separately. This test was repeated three 
times. 
 
Recovery (Matrix extraction efficiency) test 
Three levels (LOQ, 10 LOQ and 100 LOQ) of standard solution were spiked in 
dermal patches, gloves, socks, mask, glass fiber filter, and solid sorbent. The 
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extraction and analysis of acetamiprid were repeated three times according to 
the method described in the above analytical procedure. 
 
Extraction of acetamiprid from exposure matrices 
The dermal patches, gloves, mask, and socks were placed in glass bottle (100 
or 500 mL) and extracted using 50 or 300 mL of methanol, depending on matrix 
size. Solid sorbent and glass fiber filter were placed into a 20 mL vial, and 10 
mL of methanol was added. Those containers were shaken for 1 h in a shaker 
(Wooju Scientific, Kimpo, Korea) at room temperature. A sample of 1~2 mL of 
each extract was filtered through a 0.2 μm pore syringe filter (4 mm, Milipore, 
Bill, USA) before aliquots were analyzed using HPLC. 
 
Field trials and sampling procedure  
For exposure measurement during mixing/loading, only gloves were used and 
operators prepared spray mixture by mixing acetamiprid WP with water after 
weighing a specific amount of powder. The mixture was stirred mechanically 
or by stick with hands on speed sprayer (Model TLD ASS-555, Asia Motors, 
Daegu, Korea). After mixing/loading, gloves were removed for analysis. In the 
case of spraying, dermal patches (Kim et al., 2012) were attached on 13 parts 
of body: head (1), front of neck (1), back of neck (1), chest/stomach (1), back 
(1), upper arm (2), forearm (2), thigh (2), and lower leg (2). And the operator 
wore cotton gloves, cotton socks, and mask (face exposure; 200 cm2). 
Application of spray mixture to apple trees was carried out using speed sprayer 
in field for 35~45 min. The operator started spraying following their usual 
technique, with no other instructions. The application was carried out by 
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driving along the row. After the application was finished, the all materials were 
carefully removed avoiding accidental contamination of the different part and 
all samples were placed in individual plastic bags.  
PAM was used to monitor inhalation exposure. A glass fiber filter cassette 
and a solid sorbent were attached to the breathing zone with clip, and a personal 
air pump was fastened on waist by belt. After mixing/loading or spraying, solid 
sorbent and filter were removed for analysis. The flow rate of personal air pump 
was 60 L/h. 
 
Calculation of potential dermal and inhalation exposure 
PDE per body part were calculated multiplying the unit amount of acetamiprid 
(μg/cm2) on dermal patch or mask with each surface area (cm2) of body region 
for Korean, which recently suggested by Kim et al. 2011. The inhalation 
exposure rate (μg/h) was obtained by dividing the inhalation exposure amount 
(μg) by work time (h), and it was extrapolated to medium exercise (1,270 L/h) 
breathing rate for Korean male (Kim et al., 2011) to calculate potential 
inhalation exposure (PIE). 
 
Risk assessment  
The risk assessment was carried out by modifying MOS formula in report of 
Huges et al. 2008. The MOS in obtained as follows: MOS = AE / [(PDE x AF) 
+ PIE] x SF. Where AE (acceptable exposure) = AOEL (0.124 mg/kg/d) x 
average body weight (60 kg); PDE = potential dermal exposure; AF = 
absorption factor and SF = safety factor. The PDE and PIE values were obtained 
by extrapolating of application time to 4 h for effective exposure per day. AF 
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of 0.01 was used by the assumption of 10% of dermal absorption and 10% of 
cloth penetration. Thus, the actual formula used was: MOS = 0.124 x 60 / [(PDE 

























Results and discussion 
Method Validation 
The analytical and sampling methods were fully validated through the various 
experiments as follows. LOQ was calculated as 4 times greater than LOD and 
the values were low enough for the detection of acetamiprid (Table 9). Good 
reproducibility (C.V. < 4%) showed that instrument was stable for analysis. 
Acetamiprid concentration and the response of the detector was linearly 
correlated (R2 > 0.999) over the range of 0.1~10 mg/L for 3 days. Recovery 
tests of acetamiprid from various sample matrices were conducted and ranged 
from 85.3 to 118.2 % with the small relative standard deviation values 
(1.1~9.1), indicating the analytical procedures are reliable (Table 10).  
To validate the sampling method in inhalation exposure monitoring, 
trapping efficiency test and breakthrough test were performed. The trapping 
efficiency test was to measure the efficiency of solid sorbent for the trapping of 
pesticide in air. This experiment allowed a mass balance of over 96.4% by 
adding up the acetamiprid trapped in the solid sorbent and the residue at the 
bottom of the U-shaped glass tube. Most of acetamiprid remained at the bottom 
of the U-shaped glass tube because it was not volatile. The breakthrough test 
evaluates the capacity of the solid sorbent to retain pesticide. The result of over 
93.8% recovery from first part of resin without escaping to second part 
suggested that first part of resin has enough capacity to retain the corresponding 
amount of acetamiprid (Table 11). The validated approaches have been applied 
to assess potential exposure of the operator spraying acetamiprid in apple 






Table 9. LOD, LOQ, reproducibility of analysis and linearity of calibration 
curve of acetamiprid 
LOD LOQ 
Reproducibility (Area) 






0.25 ng 1 ng 
1 4.4 3.6 Day of preparation 1.0000 
10 46.8 1.0 After 1 day 0.9999 
50 238.6 0.9 After 3 day 0.9999 
aCoefficient of variation. 




Table 10. Recovery of acetamiprid from dermal patches, gloves, masks, 



















































aLOQ: limit of quantitation. 
















Table 11. Trapping efficiency and breakthrough test of solid sorbent for 
acetamiprid 





First partd 93.8 
Second parte 0 
aThe tests were carried out at 10 limit of quantitation level. 
bAmount left on the bottom of U-shaped tube. 
cAmount trapped in solid sorbent. 
dFirst part of solid sorbent. 






PDE and PIE 
In this study, cotton gloves were used for measurement of potential dermal 
exposure to the operator’s hands (Capri et al., 1999; Vercruysse et al., 1999) 
because they can be changed very quickly and that the provided some degree 
of safety for the operators, especially when using solid formulations 
(Tuomainen et al., 2002) even though exposure maybe overestimated if cotton 
is more absorbent than skin (Fenske et al., 1989). Only hands exposure were 
measured using gloves since the hands were reported to be significantly more 
exposed than the other body parts of the mixer and loaders (Kuye et al., 2008).    
Data for hands exposures amount during mixing/loading were expressed 
total amount (μg) and not time rate, as this step was not time dependent(Hughes 
et al., 2006). Exposure amount of hands during mixing/loading acetamiprid 
showed variable results (33~1,132 μg) (Table 12).  
Exposure amount of operator 3 among 4 workers was noticeably high 
because he opened the WP package, rinsed the package in the water, and stirred 
it by stick while other workers opened WP package and mixed it with water by 
machine. The results also show that application habit can give rise to the high 
variability of the operator’s exposure (Table 12). As shown in Table 13, the 
average PDE of acetamiprid during application ranged from 535 to 1,235 mL/h 
which is corresponding to 0.03~0.08% of the applied amount. The level of 
exposure is known to be variable, depending on many different factors such as 
the type of crop, crop size, application technique, weather conditions, personal 
protective equipment, etc. (Machera et al., 2002b; Tuomainen et al., 2002; 
Hughes et al., 2006). In the cases of operator 1 and operator 2, higher exposure 
rate was found than those of operator 3 and operator 4. This result could be due 
to the narrower space between the trees and more windy condition when 
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compared to other operators. Thigh was the most contaminated part with a rate 
of 224.9 mL/h (26.6%) then the next was chest (16.8%). In the same sense, 
when exposure was studied in apple orchard during application of methomyl, 
thighs and chest were identified as the most exposed body parts (Kim et al., 
2012b). Other majorly exposed parts were upper arms, forearms and lower legs. 
Head and face exposures were also relatively high (Fig. 4). Inhalation exposure 
was monitored during the application and found to be around 10-8% of applied 
amount (Table 14). The highest inhalation exposure was observed with operator 
2, probably due to relatively more windy weather during application.  
However, Cattani et al. (2001) reported that inhalation of chlorpyrifos was 





Table 12. Hands exposure during mixing/loading of acetamiprid 
Operator 
Hands exposure (mL/h) 
Minimum Maximum Average Ratio to applied a.ia (%) 
1 65.8 542.7 84.3 4.6 x 10-4 
2 45.3 400.3 169.2 4.2 x 10-4 
3 168.7 1132.1 649.3 1.6 x 10-3 




Table 13. Dermal exposure of each body part during application of 
acetamiprid 
Body part 










Head 58.6 62.8 44.2 35.8 50.3 
Face 5.8 22.1 7.7 2 9.4 
Front of neck 11.4 15 11 6.2 10.9 
Back of neck 9.9 7.1 5.3 3.4 6.4 
Chest/stomach 258.3 142.5 75.3 75 137.8 
Back 104.3 52.4 73.7 49.9 70.1 
Left upper arm 59.9 54.6 36 16.8 41.8 
Right upper arm 67.4 67.6 70.9 56.3 65.5 
Left forearm 53.6 43.8 41.1 15.4 38.5 
Right forearm 47.7 33.1 33 28.4 35.6 
Hands 36.1 38.5 16.8 28.3 29.9 
Left thigh 161.8 123.3 75.3 61.3 105.4 
Right thigh 177.3 131.6 101.8 67.4 119.5 
Left lower leg 102.9 65 42.7 52.6 65.8 
Right lower leg 75.9 66.2 54.1 35.5 57.9 
Feet 4.1 1 1.9 1.2 2.1 
Total 1235.1 926.6 690.5 535.3 846.9 
Ratio to applied a.ia 
(%) 















Figure 4. Acetamiprid dermal exposure (%) distribution in head, face, 




















































Table 14. Inhalation exposure amount during application of acetamiprid 
Operator 
Inhalation exposure (μg) 
Average Ratio to applied a.ia (%) Ratio to dermal exposure (%) 
1 0.009 2.3 × 10-8 2.8 × 10-5 
2 0.014 3.6 × 10-8 6.9 × 10-5 
3 0.006 1.5 × 10-8 5.2 × 10-5 
4 0.005 1.2 × 10-8 4.0 × 10-5 









MOS and Risk Assessment  
In risk assessment PDE values are considered together with the toxicological 
data for insecticide, then the resulting MOS values indicates that the spray 
procedure evaluated can be considered safe or not (Hughes et al., 2006). A value 
of MOS ≥ 1 would indicate safe working conditions, whereas a MOS < 1 would 
mean unsafe conditions. In MOS calculation (Table 15), AE values are 
calculated on the basis of appropriate toxicological end point such as AOEL 
(Acceptable Operator Exposure Level) or NOAEL (No Observed Adverse 
Effect Level). If AOEL is available, NOAEL is not applicable and SF is 1. 
AOEL was found to be 0.124 mg/kg/d (EC, 2004). Average body weight for 
man is 60 kg (Choi et al., 2006; Kim et al., 2012). For dermal absorption, 10% 
of dermal absorption (Choi et al., 2006; Hughes et al., 2008; Ramos et al., 2010; 
Kim et al., 2012) and 10% of cloth penetration (Choi et al., 2006; Kim et al., 
2012) were assumed, while 100% penetration was applied for inhalation 
(Oliveira and Machado-Neto 2003; Kim et al., 2012). When no inhalation data 
was available, Huges et al. (2008) assumed a dermal exposure of 1%. However, 
many study reported around from 10-4 to 10-2% levels of dermal exposure 
including this study (Capri et al., 1999; Machera et al., 2003; Oliveira and 
Machado-Neto 2003; Kim et al., 2012). Calculated MOS values (5.6~15.2) was 
much higher than 1 in all cases, indicating that the working condition was of 
least risk.   
 
Database for model  

















exposure (mg/day)a 132.10 83.92 49.06 50.11 78.80 
Potential inhalation 
exposure (μg/day) 0.04 0.06 0.02 0.02 0.03 
MOS per operatorb 5.6 8.9 15.2 14.8 11.1 
aIncluding mixing/loading 
bCalculated as MOS (margin of safety) = 0.124 mg/kg/d x 60 kg / [(PDE x 





Table 16. Dermal exposure per hour of acetamiprid (mL/h)  
Trials 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Head 95.6  79.4  61.1  47.9  72.6  47.1  40.2  27.1  22.4  53.2  55.7  65.8  98.6  43.3  80.7  
Neck of front 9.2  19.1  13.2  4.6  16.0  7.0  20.6  3.8  8.0  14.2  18.7  16.1  34.4  10.8  15.4  
Neck of back 14.9  16.7  8.1  5.3  15.7  5.7  10.1  3.1  1.9  8.9  6.9  8.1  8.3  5.6  7.3  
Chest 302.3  576.3  204.0  84.3  374.0  114.3  363.1  19.3  38.9  129.7  31.1  97.9  287.5  122.9  171.5  
Back 248.2  198.0  27.6  30.4  73.5  67.2  138.2  23.0  7.2  33.1  60.6  70.1  45.6  95.1  52.4  
Upper arm(L) 3.0  7.7  2.1  1.3  2.6  7.5  20.5  1.6  5.5  7.0  7.1  13.5  104.9  10.9  16.2  
Upper arm(R) 58.6  140.8  78.9  15.0  53.6  57.0  66.3  36.8  13.9  55.6  39.2  60.0  89.3  13.4  60.9  
Forearm(L) 43.8  129.2  79.5  46.6  121.9  48.7  23.1  8.3  23.1  33.0  42.7  91.3  120.7  32.3  63.8  
Forearm(R) 62.9  82.0  57.7  26.6  81.1  42.3  68.5  32.3  19.2  40.3  20.6  70.5  85.4  20.2  46.8  
Thigh(L) 34.7  96.5  46.1  21.2  77.1  31.3  58.2  12.7  1.9  44.6  45.7  52.2  15.3  39.5  22.2  
Thigh(R) 316.9  242.9  160.8  27.1  167.0  82.1  281.4  21.6  40.6  82.8  102.7  139.2  206.3  72.1  149.9  
Shin(L) 256.7  255.1  167.6  92.9  287.7  120.5  195.7  17.2  46.1  63.9  135.9  87.6  148.2  146.8  205.2  
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Shin(R) 165.2  182.7  85.4  31.9  119.0  76.9  90.4  29.7  28.9  97.1  72.4  75.4  107.6  31.2  64.5  
Face 67.9  139.6  55.2  20.9  108.3  80.4  98.8  14.3  32.6  100.6  76.3  48.5  90.1  48.1  67.9  
Hands 6.0  14.8  2.4  1.6  2.7  1.0  2.3  0.2  1.9  0.4  0.7  0.5  1.0  0.7  1.8  
Feet 32.6  52.5  27.1  19.4  58.9  28.2  53.1  11.0  8.0  26.7  24.0  34.8  54.1  41.8  56.5  





Table 16. Continued 
Trials 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
Head 82.0  58.5  9.6  23.3  74.7  69.0  60.8  25.2  21.5  21.3  35.7  23.9  67.1  29.9  51.4  
Neck of front 9.0  12.4  0.9  7.0  20.8  15.1  15.3  1.6  2.1  3.9  3.7  2.9  14.2  3.8  13.1  
Neck of back 10.5  5.3  1.4  5.4  12.5  2.0  11.7  2.8  3.1  2.0  2.0  2.3  7.6  3.0  3.6  
Chest 289.6  133.5  13.8  50.8  151.7  84.7  112.8  47.7  45.4  53.6  100.0  29.2  165.3  34.8  96.8  
Back 32.8  58.6  5.4  41.4  105.3  142.8  28.0  51.5  19.2  26.4  50.8  40.6  107.8  30.9  73.5  
Upper arm(L) 23.3  14.7  1.5  1.1  18.4  9.7  16.7  1.6  0.3  0.9  0.8  1.9  3.7  1.5  4.8  
Upper arm(R) 111.0  25.2  4.5  48.2  38.9  52.3  86.5  8.8  4.0  8.2  24.0  10.1  24.5  10.3  36.3  
Forearm(L) 135.3  80.5  11.9  45.7  120.7  105.1  86.5  45.9  23.1  30.8  26.2  64.4  116.1  49.7  83.6  
Forearm(R) 49.1  29.4  2.3  45.6  52.6  63.9  58.6  7.7  6.0  6.3  22.5  6.1  24.2  9.2  33.1  
Thigh(L) 23.6  42.1  14.6  33.0  61.2  23.2  49.2  16.8  8.8  5.1  24.7  27.9  73.5  8.9  49.8  
Thigh(R) 232.6  102.8  7.3  72.0  116.0  105.8  160.4  16.4  58.7  31.4  58.4  61.8  88.9  43.9  85.8  
Shin(L) 223.7  155.7  12.6  69.5  224.7  100.5  224.2  42.4  41.9  44.1  24.4  55.4  145.4  60.8  99.8  
72 
 
Shin(R) 90.3  16.4  1.0  28.8  40.4  100.4  164.6  71.8  27.1  13.9  40.8  38.5  147.2  28.4  72.0  
Face 79.8  70.7  13.9  26.8  100.5  75.0  119.2  36.0  23.9  12.6  38.9  12.4  120.4  17.7  22.3  
Hands 1.8  2.1  0.4  0.5  3.2  3.4  1.0  2.4  0.3  0.6  0.0  0.9  2.1  1.0  3.6  
Feet 52.7  45.0  5.2  12.8  5.9  43.3  75.2  17.4  12.0  18.1  22.1  22.9  42.7  24.4  55.5  


















Comparative Exposure of Operators to Fenthion during 














Cultivation of rice is important in Korea, because it is the staple food of the 
country. Furthermore, 214 insecticides are registered for rice cultivation; 
therefore, many kinds of pesticides are applied from seed stage for successful 
harvest. Thus, the appropriate exposure assessment is required to assure the 
operator’s health (or healthy agricultural practices). 
Fenthion, one of the insecticides for rice, has been used for many years in 
Korea to control fruit flies, leafhoppers, leaf miners, leaf-eating, larvae, stem 
borers, cereal bugs, and other insect pests (Tomlin, 2009). Its mode of action is 
through the inhibition of acetylcholine esterase. It is known to affect the central 
nervous, cardiovascular, and respiratory systems of mammals including 
humans. Being similar with other organophosphates, fenthion is readily 
absorbed through the skin (Kerem et al., 2007).  
In the present study, the exposure of fenthion to operators was monitored 
during mixing/loading and during the application of pesticide. Operators wore 
typical paddy field garment consisting of long-sleeved polyester shirts and 
impermeable trousers under rain boots. To monitor exposure in application, 
patches (Tuomainen et al., 2002; Kuye et al., 2007) were placed on the outer 
clothing over the following body parts: head, front of neck, back of neck, upper 
arms, forearms, thighs, lower legs, back, and chest. Hand exposure was 
monitored by means of cotton gloves (González et al., 1999; Ramwell et al., 
2005), whereas face exposure was measured using cotton mask (200 cm2) 
(Machado-Neto 2001; Choi et al., 2006). For inhalation exposure, personal air 
monitor was employed (Cattani et al., 2001; Machera et al., 2003). During 
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mixing/loading of pesticide, only gloves were used for exposure measurement, 




Materials and Methods 
Reagents and materials  
Fenthion (WG, 50%, Sungbo Chemical, Seoul, Korea) was obtained through 
the local vendor. Analytical standard of fenthion (purity, 98.3%) was purchased 
from the Sigma-Aldrich. (West chester, PA). All solvents were HPLC grade, 
and purchased from Burdick & Jackson (SK Chemical, Ulsan, Korea).  
 
Sampling methodology 
The potential dermal exposure and inhalation exposure was measured using the 
patch technique as part 2.  
 
Calculation of dermal and inhalation exposure 
The potential dermal exposure and inhalation exposure was measured using the 
patch technique as part1 reported.  
 
Analytical condition 
For the analysis of fenthion in various exposure matrices, an Agilent 6890 gas 
chromatograph (GC; SantaClara, CA, USA) with a nitrogen phosphorus 
detector was used with a DB-5 column (30 m × 0.25 mm, 0.25 μm; J&W 
Scientific, Folsom, CA, USA). Sample injections (1 μL) were performed in split 
mode (20:1) at 260 °C. The column temperature was maintained at 150 °C for 
1 min, elevated at a rate of 10 °C/min to a temperature of 210°C for 2 min, 
elevated at a rate of 20 °C/min to a final temperature of 300°C. Nitrogen gas 







Aliquots of standard solutions from 0.01 to 5 mg/L were analyzed for 
determination of instrumental limits of detection (ILODs) and instrumental 
limits of quantitation (ILOQs). The method limits of quantitation (MLOQs) 
were calculated from ILOQs, injection volume and extract solvent volume in 
analytical method. After injecting three levels (MLOQ, 10MLOQ and 100 
MLOQ) of standard solution 7 times, C.V. values of the integrated peak area 
was determined to validate instrumental repeatability. Various standard 
solutions (LOQ level) were analyzed and the linearity of the curve was 
investigated after one day and three days of preparation. For recovery test, 
control exposure samples were fortified in three levels (MLOQ, 10 MLOQ and 
100 MLOQ) of standard solution. The trapping efficiency was tested by spiking 
two levels of standard solution (10 MLOQ and 100 MLOQ) on the bottom of 
U-shape glass tube (Daejung Chemical, Daejeon, Korea) connected with solid 
sorbent, and passing air through the system at 1 L/min for 4 h. U-shape glass 
tube was heated to 70oC to help volatilization of compounds. The residue in U-
shape glass tube and the amount trapped in XAD-2 resin were analyzed for 
mass balance. Breakthrough test was conducted by spiking two levels of 
standard solution (10 MLOQ and 100 MLOQ) in the 1o-resin part of the solid 
sorbent tube and passing air through the tube at 1 L/min for 4 h. Subsequently, 
1o- and 2o-part of resin were analyzed separately. All analysis and test were 
repeated 3 times. 
 
Sampling and field experiment 
Field study was conducted in paddy field, and four operators, who have similar 
experiences in agricultural practices (over 40 years) participated in exposure 
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study. Each of them carried out mixing/loading and the application of pesticide 
by repeating two times.  
Operators prepared spray mixture by mixing 500 mL of fenthion EC 
(emulsifiable concentrate, 50%) in 500 L water to spray it on rice plants during 
growing stage. Temperature and relative humidity during this field study 
ranged from 29 to 31℃ and 47 to 60%, respectively. All exposure samples 
were kept frozen when not analyzed immediately. Dermal exposure estimates 
were calculated by extrapolating patch deposition values to the total surface 
area (cm2) of the appropriate body region for Koreans (Kim et al., 2011). 






Results and Discussion 
Method validation 
Method validation for exposure monitoring of fenthion was carried out. LOD 
and LOQ were 0.01 and 0.05 ng, respectively. Calibration curve linearity 
(R2>0.999) and reproducibility (CV<3%) were also excellent. Recovery at 
LOQ, 10LOQ and 100LOQ levels from gloves, socks, mask, patch, solid 
sorbent, glass fiber filter was 76~113% (C.V<3%). Trapping efficiency was 
95~105% while no breakthrough was observed. Method validation for the 
exposure monitoring was established successfully through several experiments. 
Such method validation can be usually performed in laboratory and not much 
different for each pesticide so that, this techniques will be applied widely in 
research for pesticide exposure monitoring by combination with body surface 
area and respiration rates. 
 
Potential dermal exposure and inhalation assessment 
Hand exposure during mixing/loading was 0.04~33.06 mg (Table 17), which 
suggests personal habit or mistake can result in great difference of exposure, 
even though they have similar work experiences. In the case of operator 2, 
difference of approximately 600-fold was observed in repetition. Such 
difference is very important result, because that situation suggests that careful 
handling is essential in mixing/loading procedure, and many repetitions of 
experiment are critical to obtaining statistically significant exposure results. 
During spray of fenthion, exposure differences were also observed between 
repetition and operators, but it was not as serious as in the case of 
mixing/loading. However, operator 2 still shows the greatest difference 
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between repetitions, suggesting he is generally not careful in treatment of 
pesticide. When the exposure pattern on body was examined based on the 
average data of 7 repetitions (data of first repetition of operator 3 was discarded 
due to the missing of dermal patches of legs and arms), most of the exposure 
occurred in applicators’ legs and hands (Table 18). Leg exposure accounted for 
54% of total average exposure, whereas hands accounted for 28%. Torso, arms, 
and head/face parts accounted for 6, 10, and 2%, respectively (Fig. 5). Leg 
exposure was considerably higher than that in the upper body, probably due to 
direct contact with the contaminated rice plants during spraying. Under 
comparable field conditions, Farahat et al. (2010) reported similar exposure 
patterns of higher exposure rate in thighs than in forearms. These results again 
emphasize the importance of wearing impermeable protective trousers and 
gloves for operators’ safety. In most of cases, inhalation exposure is estimated 
as 1% of dermal exposure when inhalation exposure data are not available 
(Machdo-Neto et al., 1998; Hughes et al., 2008). However, in the present study, 
inhalation exposure was observed at 0.001~0.2% of dermal exposure. Such 
findings are in agreement with other studies, which reported normally 
respiratory exposure occupies less than 1% in the field environment (Capri et 
al., 1999; Machera et al., 2003; Oliveira and Machado-Neto 2003; Kim et al., 
2012). In conclusion, high variability of dermal exposure level and its 
distribution on the body parts were observed between repetitions and operators, 
indicating exposure results vary widely depending on applicator’s habit, 
condition of field, weather, and other different factors as mentioned by Hughes 
et al. (2006). It is strongly recommended for operators to wear personal 
protective equipment to avoid direct and extreme exposure to pesticides during 
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treatment of pesticide. Due to the high variability of exposure data, a great 
numbers of repetitions are necessary to establish comprehensive exposure 




Table 17. Exposure amount and ratios during mixing/loading and 
application of fenthion in paddy field 
 
Operator 1 Operator 2 Operator 3 Operator 4 
1 2 1 2 1 2 1 2 
Mixing/applied 
amount (g) 250 
Dermal exposure during mixing/loading 
Total exposure 
amount (mg) 0.17 0.10 0.05 33.06 0.03 0.04 0.04 12.02 
Ratio to prepared 
amount (%) 7×10
-5 4×10-5 2×10-5 1×10-2 1×10-5 2×10-5 2×10-5 5×10-3 
Dermal exposure during application 
Total exposure 
amount (mg) 27.2 44.9 36.3 288.3 1.3 44.7 20.3 26.5 
Ratio to applied 
amount (%) 0.01 0.02 0.01 0.12 0.001 0.02 0.01 0.01 
Inhalation exposure during application 
Total exposure 
amount (μg) 1.7 8.5 7.1 8.4 2.6 9.2 0.3 2.3  
Ratio to applied 
amount (%) 7×10
-7 3×10-6 3×10-6 3×10-6 1×10-6 4×10-6 1×10-7 9×10-7  
Ratio to dermal 

































































Table 18. Dermal exposure (mg) during application of fenthion in paddy field 
 
Operator 1 Operator 2 Operator 3 Operator 4 
1 2 Av 1 2 Av 1 2 Av 1 2 Av 
Head 0.88 0.21 0.54 0.20 0.55 0.37 0.07 0.00 0.03 0.05 0.83 0.44 
Front of neck 0.20 0.03 0.12 0.10 0.29 0.20 0.00 0.01 0.01 0.03 0.13 0.08 
Back of neck 0.58 0.08 0.33 0.01 0.04 0.03 0.02 0.00 0.01 0.04 0.72 0.38 
Chest/stomach 3.37 0.97 2.17 0.65 1.43 1.04 0.13 4.12 2.12 0.30 3.32 1.81 
Back 3.39 0.71 2.05 0.71 2.02 1.37 0.27 0.12 0.20 0.47 3.75 2.11 
Face 1.28 0.26 0.77 0.21 0.17 0.19 0.00 0.60 0.30 2.27 2.03 2.15 
Upper arm (left) 1.17 0.18 0.67 0.14 0.47 0.30 0.08 0.15 0.11 0.10 0.69 0.39 
Upper arm (right) 1.20 0.16 0.68 0.31 0.79 0.55 0.22 0.00 0.11 0.00 0.43 0.22 
Forearm(left) 1.17 0.30 0.73 0.08 0.13 0.11 ㅡ a 31.18 15.59 0.79 1.00 0.89 
Forearm(right) 2.61 0.29 1.45 0.32 1.05 0.68 0.00 2.14 1.07 0.72 0.61 0.67 
Thigh(left) 2.92 4.01 3.47 4.33 92.84 48.58 0.01 2.10 1.05 4.33 6.09 5.21 
Thigh(right) 6.08 5.41 5.75 5.35 96.85 51.10 0.50 2.22 1.36 6.26 5.37 5.81 
Lower leg (left) 0.83 0.68 0.75 2.05 2.93 2.49 ㅡ a 0.92 0.46 1.81 0.61 1.21 
Lower leg (right) 0.69 1.02 0.85 2.21 2.56 2.38 ㅡ a 0.40 0.20 1.72 0.40 1.06 
Feet 0.02 0.04 0.03 0.02 0.12 0.07 0.00 0.27 0.13 0.75 0.12 0.43 
Hand 0.86 30.48 15.67 19.59 86.11 52.85 0.00 0.51 0.25 0.73 0.39 0.56 
Total 27.24 44.85 36.05 36.29 288.35 162.32 1.30 44.73 23.02 20.35 26.49 23.42 




Health risk to operators was evaluated by margin of safety (MOS) 
calculation (Choi et al., 2006; Ramos et al., 2010) using 5 mg/kg of 2 
year rat short term dietary NOEL (Tomlin, 2009) for fenthion and 4 h of 
the regular spray time per day (Table 19). In calculation of MOS, 
repetition 2 of operator 2 was not considered due to its extremely high 
value, which probably resulted from careless handling of pesticide. 
Repetition 1 of operator 3 also was not considered due to loss of dermal 
patches during application. Margin of safety shows similar tendency 
over 1, indicating that application works were safe enough to be carried 
out. 
 
Database for model 




Table 19. Calculation of MOS for application of fenthion in paddy field 
 PDEa EDEb IDEc PIEd AQEe MOS 
Operator 1 217.07 21.71 2.17 20.33 2.19 1.37 
Operator 2 218.00 21.80 2.18 28.34 2.21 1.36 
Operator 3 268.64 26.86 2.69 36.67 2.72 1.10 
Operator 4 176.67 17.67 1.77 5.15 1.77 1.69 
*Data of repetitions 2 
aPotential dermal exposure, exposure amount x 4hr (mg/day), including 
mixing/loading 
bExternal dermal exposure, PDE x 10% (mg/day) 
cInternal dermal exposure, EDE x 10% (mg/day) 
dPotential inhalation exposure, exposure amount x 4hr (μg/day) 




Table 20. Dermal exposure per hour of fenthion (mL/h)  
Trials 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Head 0.51  0.00  0.18  2.63  0.24  0.23  0.39  0.59  1.65  0.64  0.22  5.26  0.09  0.00  0.00  
Neck of front 0.05  0.00  0.12  0.61  0.43  0.05  0.07  0.30  0.88  0.09  0.05  0.53  0.00  0.00  0.09  
Neck of back 0.10  0.02  0.05  1.75  0.08  0.05  0.21  0.03  0.13  0.25  0.04  0.12  0.04  0.00  0.00  
Chest 1.30  9.07  3.32  10.10  3.89  1.14  0.00  1.96  4.30  2.91  1.08  20.80  11.07  2.05  7.01  
Back 0.08  0.02  0.00  10.17  0.07  0.06  0.00  2.14  6.06  2.14  0.06  4.54  0.96  0.00  0.16  
Upper arm(L) 0.18  0.60  3.44  3.83  1.22  1.37  0.30  0.64  0.50  0.79  0.87  4.25  0.09  0.87  1.40  
Upper arm(R) 0.24  0.00  0.52  3.50  0.41  0.13  137.73  0.41  1.40  0.55  0.00  0.19  0.00  0.76  0.00  
Forearm(L) 0.20  0.17  0.26  3.60  0.22  0.32  2.55  0.92  2.36  0.49  0.18  0.26  0.03  0.01  0.01  
Forearm(R) 1.24  3.29  2.18  3.50  0.28  3.19  7.16  0.25  0.39  0.91  0.31  3.16  0.90  1.42  1.56  
Thigh(L) 0.77  0.53  1.13  7.83  0.27  0.74  171.58  0.96  3.15  0.87  0.24  5.80  2.04  3.85  1.54  
Thigh(R) 241.23  18.89  241.44  8.77  13.61  14.08  0.00  12.98  278.52  12.03  9.56  5.47  274.80  9.80  4.25  
Shin(L) 228.54  7.19  256.66  18.24  12.42  20.16  0.00  16.06  290.56  16.24  9.88  3.88  509.92  8.89  2.31  
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Shin(R) 4.27  3.50  5.77  2.48  6.19  3.69  2.74  6.15  8.78  2.05  3.71  2.28  14.27  3.95  0.29  
Face 1.86  1.52  4.83  2.06  6.52  4.85  4.11  6.63  7.67  3.05  2.13  2.09  14.11  3.47  0.42  
Hands 2.18  0.06  0.05  0.05  0.16  60.40  71.39  0.06  0.35  0.12  0.07  0.13  0.00  53.15  3.42  
Feet 95.21  1.82  119.47  2.59  67.55  152.05  13.45  58.78  258.33  91.44  217.42  125.91  1.65  1.15  1.84  





Table 20. Continued 
Trials 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
Head 0.38  0.00  0.41  0.12  0.18  0.09  1.64  0.16  0.57  0.20  0.00  0.01  0.00  0.60  0.16  
Neck of front 0.06  0.03  0.00  0.19  0.10  0.09  0.40  0.00  0.12  0.00  0.00  0.04  0.00  0.14  0.08  
Neck of back 0.08  0.07  0.10  0.02  0.01  0.00  1.29  0.00  0.08  0.05  0.01  0.01  0.05  0.42  0.11  
Chest 1.30  5.92  0.33  6.75  0.48  2.11  9.88  0.17  10.10  0.38  3.40  12.35  1.87  14.32  0.90  
Back 2.30  0.47  1.15  0.50  0.22  0.51  5.17  0.18  1.02  0.82  0.29  0.37  0.00  2.28  1.41  
Upper arm(L) 0.62  0.17  0.97  0.46  0.47  0.30  0.75  0.70  0.13  0.00  0.27  1.81  0.50  0.72  6.80  
Upper arm(R) 0.44  0.00  0.04  0.12  0.24  0.01  1.54  0.00  0.00  0.24  0.12  0.44  0.02  0.42  0.30  
Forearm(L) 0.28  0.01  0.08  0.02  0.27  0.01  1.52  0.00  0.28  0.66  0.01  0.01  0.00  0.29  0.01  
Forearm(R) 0.09  0.25  0.62  0.28  0.11  0.54  97.74  0.00  2.20  0.00  5.52  93.55  0.00  0.99  2.36  
Thigh(L) 0.23  2.45  0.71  0.96  0.00  0.29  3.74  0.08  3.12  0.00  104.86  6.41  5.54  5.02  2.17  
Thigh(R) 11.14  769.76  4.83  6.39  17.91  8.52  13.72  18.01  15.24  0.02  5.34  6.29  17.35  585.16  12.98  
Shin(L) 5.98  467.39  5.79  9.20  17.33  6.32  13.64  210.19  16.07  1.51  4.57  6.65  217.10  530.70  18.77  
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Shin(R) 8.54  8.65  1.35  2.10  166.51  3.38  4.38  8.54  4.34  0.00  1.02  2.75  8.22  8.23  5.43  
Face 4.00  8.72  0.95  2.36  14.67  1.62  2.75  4.18  2.42  0.00  0.98  1.21  10.93  12.72  5.15  
Hands 0.00  0.00  0.00  0.06  0.05  0.08  0.55  0.06  0.22  0.00  0.30  0.80  0.11  0.39  2.24  
Feet 129.51  1.02  0.32  1.81  0.19  0.64  1.33  0.82  2.48  0.00  1.32  1.52  0.92  1.90  2.19  












Operator Exposure to Indoxacarb Wettable Powder 
and Water Dispersible Granule during Mixing/loading 











Materials and Methods 
Experimental materials 
Indoxacarb (98.3%) of analytical standard grade was purchased from Sigma-Aldrich 
(St. Louis, MO, USA). Wettable powder (WP) (10%) and water dispersible granule 
(WG) (30%) were purchased from a pesticide vender for field study.  
 
Exposure study samples and analytical conditions 
Exposure sample analysis were performed on a High Performance Liquid 
Chromatograph (Agilent 1100 HPLC; CA, USA) with automatic injector, DAD 
(diode array detector), and a YMC C18 column (250 mm × 4.6 mm, 5 μm particle; 
Kyoto, Japan) at 40℃. The mobile phases A and B were water and acetonitrile, 
respectively. An isocratic system was A 70: B30. Injection volume was 10 μL, and 
elution of indoxacarb was monitored at 310 nm. 
 
Extraction of exposure matrices 
The gloves was placed in glass bottle (500 mL) and extracted using 300 mL of 
methanol. Solid sorbent and glass fiber filter were placed into a 20 mL vial, and 10 
mL of methanol was added. Those containers were shaken for 1 h in a shaker (Wooju 
Scientific, Kimpo, Korea) at room temperature. A sample of 1-2 mL of each extract 
was filtered through a 0.2 μm pore syringe filter (4 mm, Milipore, Bill, USA) before 
aliquots were analyzed using HPLC. In case of solid sorbent and glass fiber filter, 




LOD, LOQ, and reproducibility 
Aliquots (10 μL) of indoxacarb standard solution (0.01~0.5 μg/mL) were analyzed 
for LOD determination before LOQ calculation. For reproducibility test, two levels 
(LOQ and 10 LOQ) of indoxacarb standard solution were analyzed six times by 
HPLC to calculate coefficient of variation (C.V). Various standard solutions 
(0.05~10 μg/mL) were analyzed for establishment of calibration curve. After 1 and 
3 days of storage, the linearity (coefficient determination, R2) of the curve was 
investigated again. 
 
Recovery (Matrix extraction efficiency) test 
Three levels (LOQ, 10 LOQ and 20 LOQ) of standard solution were spiked in gloves, 
glass fiber filter, and solid sorbent. The extraction and analysis of indoxacarb were 
repeated three times according to the method described in the above analytical 
procedure. 
 
Trapping efficiency and breakthrough tests 
The trapping efficiency was tested by spiking standard solution (10 LOQ) on the 
bottom of U-shape glass tube (Daejung Chemical, Daejeon, Korea) connected with 
solid sorbent, and passing air through the system at 1 L/min for 4 h. U-shape glass 
tube was heated to 70oC to help volatilization of compounds. The residue in U-shape 
glass tube and the amount trapped in XAD-2 resin were analyzed for mass balance. 
Breakthrough test was conducted by spiking standard solution (50 LOQ) in the 1o-
resin part of the solid sorbent tube and passing air through the tube at 1 L/min for 4 
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h. Subsequently, 1o- and 2 o -part of resin were analyzed separately. All analysis and 
test were repeated 3 times. 
 
Field study, calculation of exposure, and risk assessment  
Hand exposure was monitored using cotton gloves and for the analysis in exposure 
matrices. A personal air monitor (PAM) consists of air pump (Gillian Model 224-
PCXR7, MSA, Dong Ha Trading Co. Ltd, Seoul, Korea), glass fiber filter (37 mm, 
SKC, Eighty Four, PA) in open-faced cassette (SKC) and solid sorbent (ORBOTM 
609 Amberlite XAD-2 400/200 mg, Supelco, MO, USA) (Kim et al., 2012b). A glass 
fiber filter cassette and a XAD-2 resin tube were attached with clips on breathing 
zone of worker, and air pump was fastened on the belt. The air flow rate was 1 L/min. 
After mixing/loading or spraying, exposure samples were collected by preventing 
contamination. Workers prepared spray mixture by mixing indoxacarb WP and WG 
with water after weighing a specific amount of powder (62 g of WP in 250 L water 
and 41.6 g of WG in 250 L). The mixture was stirred using a long stick. After 
experiment, gloves were sampled in a zip lock bag and transferred to laboratory 
immediately analysis. Hand exposure amount was determined by multiplying 
extraction solvent amount. Inhalation exposure amount (ng) was obtained by 
extrapolating pesticide residue (ng) in an inhalation exposure matrix to the ratio of 
the air volume collected to the respiration rate of working situation (1,270 L/h) for 
adult male Korean (Kim et al., 2011). The risk assessment was carried out by (Kim 
et al., 2012b). AOEL is 0.004 mg/kg b.w./day. If MOS ≥ 1, the working condition is 
considered to be safe. 
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Results and Discussion 
Method Validation 
Method validation for the exposure monitoring was established successfully through 
several experiments. LOQ was calculated as 4 times greater than LOD and the values 
were low enough for the detection of indoxacarb. LOD and LOQ were 0.25 and 1 
ng, respectively. R2 of calibration curve linearity was more than 0.9999. Good 
reproducibility (C.V < 6%) showed that instrument was stable for analysis. Recovery 
of indoxacarb from gloves, solid sorbent and glass fiber filter at three different levels 
was 81.5~108.8% (Fig. 6). To validate the sampling method in inhalation exposure 
monitoring, trapping efficiency test and breakthrough test were performed. The 
trapping efficiency test was to measure the efficiency of solid sorbent for the trapping 
of pesticide in air. This experiment allowed a mass balance of over 112.0% by adding 
up the indoxacarb trapped in the solid sorbent and the residue at the bottom of the 
U-shaped glass tube. Because it was not volatile, most of indoxacarb remained at the 
bottom of U-shaped glass tube. The breakthrough test evaluates the capacity of the 
solid sorbent to retain pesticide. The recovery of the first adsorbent was 89.5% and 
the recovery of the second adsorbent was 0.9%. The validated approaches have been 
applied to assess potential exposure of pesticide operator mixing/loading indoxacarb 






Hand exposure, inahalation exposure and MOS 
Exposure to the dermal during the preparation of the pesticide spray solution was 
done hands because it was the most important route of exposure pathway 
(Vercruysse et al., 1999). According to a study by Machado-Neto et al. (1998), 86% 
exposure of body parts was hands. In addition, in the case of methomyl wetting 
powder, 19.0~99.9% of hand exposure was observed (Kim et al., 2012b).  
It has also been reported that the exposure of the hand during mixing/loading was 
more than the hand exposure amount when spraying (Vercruysse et al., 1999; 
Ramwell et al., 2005). Therefore, evaluation of hand exposure of pesticides is very 
important, Hand exposure measurement methods have cotton gloves(Calumpang 
and Medina, 1996; Egea González et al., 1999; Cattani et al., 2001; Kim et al., 2012a), 
hand rinse/washes, and hand wipe methods. During mixing/loading procedure, hand 
exposure amount (75 percentile of 30 repetitions) for indoxacarb WP was 6 folds 
(459.8 mg/kg a.i) than that of WG (81.4 mg/kg a.i) (Table 21). This result indicates 
that WG has less drift than WP thanks to its granular type of formulation. Inhalation 
amount was 10-8~10-7% of spray mixture prepared and 10-4~10-3% of hand exposure 
(Table 22). In inhalation case, no significant differences were observed between two 
formulations. Margin of safety was calculated for risk assessment using male Korean 
average body weight and acceptable operator exposure level as the important 
exposure factors. Mixing/loading procedures for both of the formulations were 














Figure 6. Extraction efficiency of indoxacarb from cotton gloves, XAD-2 resin 





























Table 21. Hand exposure during mixing/loading of indoxacarb 
Hand exposure  WP (mg/kg)  WG (mg/kg)  
75 percentile 459.8  81.4  
min value 12.1  2.5  



























Table 22. Inhalation exposure during mixing/loading of indoxacarb 
 WP  WG  
Exposure amount (μg, 75percentile) 0.014 0.012  
Applied a.ia (g) 6.2  12.5 
Ratio to applied a.i.a (%) 2.3 x 10-7 9.6 x 10-8 
Hand exposure (μg) 2,851 1,018 
Ratio to hand exposure (%) 4.9 x 10-4 1.2 x 10-3  



































Figure 7. Hand exposure of indoxacarb wettable powder (A) and water 






















































Hand Exposure of Operator to Chlorpyrifos during 







Materials and Methods 
Reagents and materials 
Chlorpyrifos (99.9%) of analytical standard grade was purchased from Sigma-
Aldrich (St. Louis, MO, USA). Chlorpyrifos emulsion concentrate (EC) (20%) was 
purchased from a pesticide vender for field study. Hand exposure was monitored 
using cotton gloves and for the analysis in matrices, an Agilent 6890 gas 
chromatograph (GC; SantaClara, CA, USA) with an electron capture detector. 
 
Analytical method validation 
This method validation was carried out in accordance with the method referred by 
Kim et al. (2011). Aliquots (1 μL) of standard solutions from 0.01 to 1 ppm were 
analyzed to determine the limit of detection (LOD) and limit of quantitation (LOQ). 
To validate instrumental reproducibility, 3 levels of standard solution (LOQ, 10LOQ, 
and 100LOQ) were analyzed 7 times, and the coefficient of variation (C.V.) was 
calculated. Various standard solutions were analyzed to construct a calibration curve, 
and the linearity of the curve was investigated again after 1 and 3 days of storage. 
For the recovery test, 3 levels of standard solution (LOQ, 10LOQ, and 100LOQ) 
were spiked in gloves by shaking, prior to the extraction with the 300 mL of acetone 
by 1 h shaking. 
 
Measurement of hand exposure and risk assessment 
Before the exposure assessment, all operators washed hands. Workers prepared the 
spray mixture by mixing EC (500 mL for SS) with 500 L of water in a mixing tank. 
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3 Workers made spray suspension for about 3 min. Each replicate consisted of two 
500L mixing/ loadings or applications and 30 replicates were made (60 spray of 
500L tank). After experiment, gloves were sampled in a zip lock bag and transferred 
to laboratory immediately analysis. Hand exposure amount was determined by 
multiplying extraction solvent amount.  
The risk assessment was carried out by comparing the pesticide exposure forecasted 
to the relevant risk value, AOEL. For this, the margin of safety (MOS) (Hughes et 
al., 2008a) for workers was calculated using following modified formula: MOS = 
AOEL / AQE per unit Korean male body weight (69.2 kg). AOEL of chlorpyrifos is 
0.01 mg/kg b.w./day. (PPDB, 2005). If MOS ≥ 1, the working condition is 
considered to be safe. The hand exposure was calculated using the 75th percentile of 
30 repetitions. The potential dermal exposure (PDE) values was obtained by 
extrapolating corresponding exposure 8 times. The IDE (internal dermal exposure) 
value was based on assumptions of 10% skin absorption for PDE after 10% of 




  Results and Discussion 
Method validation 
Exposure and risk assessment during mixing/loading of chlorpyrifos emulsifiable 
concentrate (EC, 20%) were carried out. Limit of detection and limit of quantitation 
were 0.02 and 0.1 ng, respectively. Good instrumental repeatability (C.V. < 6%) and 
consistent linearity of calibration curves for 3 days (R2 >0.999) showed the analytical 
instrument was precise and stable. Recovery of chlorpyrifos from gloves was 72.3-
103.4% (Fig. 8).  
 
Hand exposure and risk assessment 
During mixing/loading procedure, average hand exposure amount of chlorpyrifos 
was 3.9 mg which is corresponding to 0.004% of total active ingredient in the 
prepared spray mixture. In calculation of MOS (Margin of Safety) for risk 
assessment, male Korean average body weight and AOEL (Acceptable Operator 
Exposure Level) were used. Nine events of mixing/loading procedure were assumed 
per day. And 75 percentile of 30 repetition (4.6 mg) was used as for the worst case 
(Table 23). MOS was more than 1 for total repetition, indicating mixing/loading 
work was of least risk (Table 24). However, MOS of individual repetition was 
































































Table 23. Amount of hand exposure during mixing/loading. 
Trial 1 2 3 4 5 6 7 8 9 10 
Exposure 
(mg) 
0.9  2.6  0.7  0.4  2.8  3.2  1.8  0.5  1.7  1.6  
Trial 11  12  13  14  15  16  17  18  19  20  
Exposure 
(mg) 
3.3  7.0  1.4  1.9  4.9  2.2  24.2  2.6  1.5  1.8  
Trial 21  22  23  24  25  26  27  28  29  30  
Exposure 
(mg) 
6.6  1.6  0.9  3.6  6.5  8.0  10.3  5.1  2.9  2.6  
Minimum  0.4 mg 
Maximum 24.2 mg 
Average  3.9 mg 





Table 24. Calculation of MOS for mixing/loading of chlorpyrifos. 
PDEa (mg/day)  IDEb (mg/day)  MOSc 
39.2 0.4 5.4 
aPotential dermal exposure 
bInternal dermal exposure 


















In vitro metabolism of kresoxim-methyl 











In vitro human metabolism studies of pesticides (biotransformation) 
In vitro human metabolism studies of pesticides are very important and useful for 
prediction and management of the hazard and risk arising from introduction of 
pesticides in that understanding metabolism of pesticides. It should be emphasized 
that, although pesticides and their use have many positive attributes, in terms of their 
interactions with living organisms, pesticides are xenobiotics and are processed 
(metabolized) in the same way as other xenobiotics such as clinical drugs and 
industrial chemicals (Hodgson, 2010). The metabolism of pesticides involves three 
phase process; in first phase process (phase I) the initial properties of a parent 
compound are transformed through oxidation, reduction, or hydrolysis to generally 
produce a more water-soluble and usually a less toxic product than the parent, in 
second phase process (phase II) involves conjugation of a pesticide to a sugar or 
amino acid, which increases the water solubility and reduces toxicity compared with 
the parent pesticide, and in third phase process helps in conversion of second phase 
metabolites into secondary conjugates, which are also non-toxic (Van Eerd et al., 
2003; Verma et al., 2014). Phase I reactions involve hydrolysis, reduction, and 
oxidation. These reactions expose or introduce a functional group (–OH, –NH2, –SH 
or –COOH), and usually result in only a small increase in hydrophilicity. The 
cofactors for these reactions react with functional groups that are either presented on 
the xenobiotic or are introduced/exposed during phase I biotransformation 
(Parkinson, 2001). During the recent years, a large number of papers have been 




Table 25. Metabolism studies of pesticides by human CYPs and HLMs 
Pesticide Chemical class Usage Reference 
2,4-D Phenoxy Herbicide (Ohkawa et al., 1998) 
Acetochlor Chloroacetanilide Herbicide (Kale et al., 2008) (Coleman et al., 2000) 
Alachlor Chloroacetanilide Herbicide (Coleman et al., 1999) (Kale et al., 2008) 
Ametryne Triazine Herbicide (Cresteil et al., 1979) 
Atrazine Triazine Herbicide (Cresteil et al., 1979) (Joo et al., 2010) 
Azinphos-
methyl Organophosphate Insecticide (Buratti et al., 2003) 
Benfuracarb Carbamate Insecticide (Abass et al., 2014a) (Abass et al., 2014b) 
Bifenthrin Pyrethroid Insecticide (Scollon et al., 2009) 
Bioresmethrin Pyrethroid Insecticide (Scollon et al., 2009) 
Butachlor Chloroacetanilide Herbicide (Coleman et al., 2000) 
Carbaryl Carbamate Insecticide (Tang et al., 2002) 
Carbosulfan Carbamate Insecticide (Abass et al., 2009) 
Chlorfenvinphos Organophosphate Insecticide (Hutson and Logan, 1986) 
Chlorpyrifos Organophosphate Insecticide 
(Tang et al., 2001) 
(Buratti et al., 2003) 
(Sams et al., 2004) 
(Mutch and Williams, 
2006) 
Chlorpyrifos Organophosphate Insecticide 
(Choi et al., 2006) 
(Foxenberg et al., 2007) 
(Croom et al., 2010) 
(Smith et al., 2011) 
β-Cyfluthrin Pyrethroid Insecticide (Scollon et al., 2009) 
λ-Cyhalothrin Pyrethroid Insecticide (Scollon et al., 2009) 
Cypermethrin Pyrethroid Insecticide (Scollon et al., 2009) 
Deltamethrin Pyrethroid Insecticide (Godin et al., 2006) (Godin et al., 2007) 
Diazinon Organophosphate Insecticide 
(Kappers et al., 2001) 
(Buratti et al., 2003) 
(Sams et al., 2004) 
(Mutch and Williams, 
2006) 
(Ellison et al., 2012) 
Dimethoate Organophosphate Insecticide (Buratti and Testai, 2007) 
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Pesticide Chemical class Usage Reference 
Disulfoton Organophosphate Insecticide (Usmani et al., 2004) 
Diuron Phenylurea Herbicide (Abass et al., 2007) 
Endosulfan Cyclodiene Insecticide (Lee et al., 2006) 
Esfenvalerate Pyrethroid Insecticide (Godin et al., 2006) (Godin et al., 2007) 
Fenthion Organophosphate Insecticide 
(Furnes and Schlenk, 
2005) 
(Leoni et al., 2008) 
Fipronil Phenylpyrazole Insecticide (Tang et al., 2004) (Joo et al., 2007) 
Flucetosulfuron Sulfonylurea Herbicide (Lee et al., 2014) 
Furametpyr Anilide Fungicide (Nagahori et al., 2000) 
Imidacloprid Neonitotinoid Insecticide (Schulz-Jander et al., 2002) 
Isocarbofos Organophosphate Insecticide (Zhuang et al., 2014) 
Malathion Organophosphate Insecticide (Buratti et al., 2005) 
Methiocarb Carbamate Insecticide (Usmani et al., 2004) 
Methoxychlor Organochlorine Insecticide 
(Stresser and Kupfer, 
1998) 
(Hu and Kupfer, 2002) 
Metolachlor Chloroacetanilide Herbicide (Coleman et al., 2000) 
Molinate Thiocarbamate Herbicide (Jewell and Miller, 1999) 
Myclobutanil Triazole Fungicide (Barton et al., 2006) 
Parathion Organophosphate Insecticide 
(Butler and Murray, 
1997) 
(Buratti et al., 2003) 
(Sams et al., 2004) 
(Mutch and Williams, 
2006) 
(Foxenberg et al., 2007) 
Parathion-
methyl Organophosphate Insecticide (Ellison et al., 2012) 
Permethrin Pyrethroid Insecticide (Scollon et al., 2009) (Lavado et al., 2014) 
Phorate Organophosphate Insecticide (Hodgson, 2003) (Usmani et al., 2004) 
Sulprofos Organophosphate Insecticide (Usmani et al., 2004) 
Terbuthylazine Triazine Herbicide (Cresteil et al., 1979) 
Terbutryne Triazine Herbicide (Cresteil et al., 1979) 
Thiamethoxam Neonicotinoid Insecticide (Swenson and Casida, 2013) 
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Human liver microsomal CYP450 
The CYP superfamily consisted of more than 7,000 named sequences in 
animals, plants, bacteria and fungi. The human genome has 57 CYP genes, and 
the function for most of the corresponding enzymes is known at least to some 
degree. Fifteen individual CYP enzymes in families 1, 2 and 3 metabolize 
xenobiotics, including the majority of small molecule drugs currently in use. A 
typical feature of these CYPs is broad and overlapping substrate specificity 
(Guengerich, 2003). Cytochrome P450 enzymes are found in practically all 
tissues, with highest abundance and largest number of individual CYP forms 
present in the liver. CYPs reside also in the intestine, lung, kidney, brain, 
adrenal gland, gonads, heart, nasal and tracheal mucosa, and skin. In human 
liver CYP enzymes comprise approximately 2% of total microsomal protein 
(0.3–0.6 nmol of total CYP per mg of microsomal protein). The content of drug-
metabolizing CYPs is much lower in other tissues. While extrahepatic 
metabolism may have clinically significant local effects, systemic metabolic 
clearance of drugs occurs in the liver with a significant contribution by the gut 
wall in special cases (Pelkonen et al., 2008). Ten individual CYP forms in the 
adult human liver carry out virtually the whole CYP-mediated metabolism. 
CYP3A4 is the highest abundance form and it metabolizes the greatest number 
of drugs and a very large number of other xenobiotics. Together CYP2B6, 
CYP2C9, CYP2C19, CYP2D6 and CYP3A4 are responsible for more than 90% 
of known oxidative drug metabolism reactions (Pelkonen et al., 2008). CYP1 
Family of microsomal cytochrome P450s consists of three members, CYP1A1, 
CYP1A2 and CYP1B1. The two members of the CYP1A family (CYP1A1 and 
CYP1A2) show greater than 70% amino acid sequence identity but display very 
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different patterns of tissue expression. CYP1A1 is expressed primarily in 
extrahepatic tissues such as the lungs, lymphocytes and placenta while only 
low-level expression has been reported in liver tissue. In contrast, CYP1A2 is 
expressed primarily in the liver with little if any detectable expression in the 
extrahepatic tissues (Danielson, 2002). The CYP1A enzymes bioactivate 
several procarcinogens. CYP 1A1 activate benzo pyrene and other 
polyaromatic hydro carbons. CYP 1A2 activate aromatic amines, such as 2-
acetylaminofluorene, heterocyclic amines, and aflatoxin B1 (Omiecinski et al., 
1999). CYP 1B1 is a more recently characterized member of the CYP1 family. 
CYP1B1 is constitutively expressed in most tissues but also inducible through 
the Ah receptor pathway. CYP1B1 is involved in the metabolism of endogenous 
estrogens, as well as active in the biotransformation of heterocyclic amines 
found in charcoal broiled meats (Crofts et al., 1997). The third member of the 
CYP1 family, CYP1B1 is constitutively expressed at low levels in a broad range 
of tissues including brain, colon, heart, kidney, leukocytes, liver, lung, ovary, 
placenta, prostate, skeletal muscle, small intestine, spleen, and thymus CYP 
1A2 is universally expressed in human liver (Danielson, 2002). CYP2 family 
is the largest family of cytochrome P450s in humans comprising approximately 
one third of human cytochrome P450s sequences. This family of microsomal 
cytochrome P450s is classified into 13 subfamilies that consist of 16 functional 
genes (CYP2A6, CYP2A7, CYP2A13, CYP2B6, CYP2C8, CYP2C9, 
CYP2C18, CYP2C19, CYP2D6, CYP2E1, CYP2F1, CYP2J2, CYP2R1, 
CYP2S1, CYP2U1, CYP2W1) and 13 confirmed pseudogenes (CYP2A7PT 
(telomeric), CYP2A7PC (centromeric), CYP2A18P, CYP2B7P1, CYP2B7P2, 
CYP2B7P3, CYP2D7AP, CYP2D8P, CYP2F1P, CYP2G1P, CYP2G2P, 
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CYP2T2P, CYP2T3P). Members of the CYP2 family of cytochrome P450s play 
a significant role in drug metabolism although only CYP2A6 appears to be 
expressed to any significant degree in hepatic tissue. Other members of the 
CYP2 family are expressed in a sex-specific manner and thus it is not 
unexpected that these enzymes support the hydroxylation of steroids including 
sex-specific steroids. The CYP2A proteins, in particular are expressed at much 
higher levels in the olfactory mucosa of fetal tissues at gestational days 91- 125 
than in corresponding hepatic tissues. It has been suggested that such prenatal 
expression of xenobiotic metabolizing cytochrome P450s indicates that the 
human fetal olfactory mucosa may be an important target site for chemical 
toxicity during early development (Gu et al., 2000). CYP 2A6 may participate 
in procarcinogen activation but has a relatively minor role in drug 
biotransformation and account for only approximately 4% of total immune 
quantified human hepatic CYP. CYP 2A6 participates in nicotine metabolism. 
CYP 2B6 was previously described as a low abundance isoform in human liver, 
large inter-individual variations are observed in expression, with hepatic 
microsomal content varying from as low as 0.3 pmol/mg protein to as high as 
82 pmol/mg protein (Code et al., 1997)). CYP 2C subfamily consists of 2C8, 
2C9, 2C18 and 2C19. CYP 2C8 is only known to play a major role in the 
metabolism of the anticancer agent taxol and it contributes to carbamazepine 
ephydroxylation. CYP 2C9 is the primary enzyme responsible for the 
metabolism of tolbutamide, S-warfarin, phenytoin, losartan, ibuprofen, and 
celecoxib. CYP 3A subfamily consist of 3A4, 3A5, 3A7 and 3A43. CYP 3A 
isoforms are the most abundant in both human liver and small intestine, 
accounting for an average of 28.8% of total human hepatic CYP. The majority 
125 
 
of oxidatively bio-transformed therapeutic agents are metabolized at least in 
part by this subfamily of enzymes. CYP 3A4 is the major adult isoform and is 
universally expressed both in human liver and in the small intestine. CYP 3A5 
is polymorphically expressed in approximately 20% of the population, while 
CYP 3A7 is expressed only in fetal liver. CYP 3A43 has only been recently 
identified, and its importance in human drug metabolism remains to be 
established. Expression and activity of CYP 3A isoforms in humans show wide 
individual variability (Venkatakrishnan et al., 2001). 
 
Enzyme kinetics in metabolism 
Enzyme kinetics is study of the rate (velocity) of the enzyme-catalyzed reaction. 
It is the central approach to studying the mechanism of an enzyme-catalyzed 
reaction. A key factor affecting the reaction rate by a specific enzyme is the 
concentration of substrate, [S]. However [S] is in dynamic changes and 
converted to [P], which is complicated to studying the effects of substrate 
concentration by the fact that [S] changes. One simplifying approach in kinetics 
experiment is to measure the initial velocity, V0, at high substrate concentration. 
A simple enzymatic reaction might be written 
E + S ↔ ES ↔ EP ↔ E + P 
E, S, and P represent the enzyme, substrate, and product, respectively. ES and 
EP are transient complexes of the enzyme with the substrate and with the 
product. Enzyme exists in two forms, E and ES. At low substrate concentrations, 
V0 = k[S]. Where V0 is the initial velocity, at high substrate concentrations, V0 = 
Vmax (maximum velocity). 
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Enzyme reaction is divided in three states. In the short time prior to the 
steady state, there is a burst of ES complex formation as substrate is quickly 
bound by empty enzyme. The submaximal rate of substrate utilization and 
product formation reflects the fact that it takes some time for the ES complexes 
to form; Pre-steady state. While the initial [S] is much greater than [E]t, a steady 
state is maintained where ES is formed at the same rate as it is decomposed: 
d[ES]/dt ≈ 0. Here, the rate of product formation is at Vmax. [S] decreases at it 
are converted to P. When [S] approaches [E]t, [ES] begins to drop as there is 
not enough S to keep E saturated, and the steady state assumption is no longer 
valid. Note that this region is not describing equilibrium, just a lack of readily 
available substrate for the enzyme, for I are still ignoring the reverse reaction 
for product formation. The measured V0 is generally reflects the steady state, 
even though V0 is limited to the early part of the reaction, and analysis of these 
initial rate is referred to as steady-state kinetics. The curve expressing the 
relationship between [S] and V0 has the same general shape for most enzymes, 
which can be expressed algebraically by the Michaelis-Menten equation. The 
equation is  
V0 = (Vmax ∙ [S]) / (Km + [S]) 
 
The important terms are [S], initial velocity V0, maximum velocity Vmax, and 
Michaelis constant Km. The Michaelis constant is equal to the substrate 
concentration that sufficient to give half the maximum velocity for the enzyme. 
One should get an intuitive feeling for the magnitude of Km. A small 
concentrations of substrates are sufficient to saturate the enzyme and to reach 
the maximum catalytic efficiency of the enzyme. These Km and Vmax values were 
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then used to calculate the intrinsic clearance value (Clint = Vmax / Km), the 
functional ability of the enzyme. Most metabolite kinetics studies involve the 
use of hepatic microsomes, which contain a mixture of several CYP isoforms 
with overlapping specificity, and the observed rates of metabolism reflect the 
net effect of several protein-drug interactions. In some cases there may be a 
smoothing over of any irregularities and the kinetics may look hyperbolic due 
to the ‘candling out’ of different kinetic features. In other cases, complications 
can arise due to the differing impact of several isoforms at different substrate 
concentrations. Such complications are absent when purified and recombinant 
enzymes are used, and for many drugs metabolic kinetics can be analyzed 
appropriately by the Michaelis-Menten equation (Tassaneeyakul et al., 1993; 
Veronese et al., 1993). However, the full capacity of the organ will only be 
estimated when appropriate allowance is made for the consequences of both 
parallel and sequential pathways of metabolism. The integration of the total 
hepatocellular activity with the other physiological determinants of liver 
clearance, namely, blood flow and drug binding on the blood matrix, requires 
the use of a pharmacokinetic model. Pharmacokinetics is the study of the 
absorption, distribution, metabolism, and excretion of chemicals to describe the 
time course of the chemical in the body. The aim is to provide data to enable an 
understanding to be made of the safety of the compound to the manufacturer, 
user and consumer of treated produce. Basic pharmacokinetic parameters will 
provide information on the potential for accumulation of the test substance in 
tissues and/or organs and the potential for induction of biotransformation as a 




Materials and Methods 
Chemicals and reagents 
Pooled HLMs (Table 26), and 10 different cDNA-expressed human 
recombinant P450s, CYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4, and 
3A5 (Supersomes) were purchased from BD Gentest (Woburn, MA, USA). 
Glucose-6-phosphate, glucose-6-phosphate dehydrogenase, nicotinamide 
adenine dinucleotide phosphate (NADP+), nicotinamide adenine dinucleotide 
phosphate reduced (NADPH), potassium phosphate monobasic/dibasic, and 
magnesium chloride were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Acetonitrile was HPLC grade (Fisher Scientific CO., Pittsburgh, PA, 
USA) and the other chemicals were of the highest quality available.  
 
Analytical instruments and conditions 
LC–MS/MS analysis was performed on LCMS-8050 (Shimadzu, Japan) 
coupled to Nexera UHPLC (Shimadzu, Japan) with electrospray (ESI, positive 
mode). The analytical column was a Kinetex C18 (100 × 2.1 mm i.d., 2.6 μm, 
Phenomenex®, USA) and the column oven temperature was 40ºC. The 
injection volume was 2 μL and the mobile phases were eluted at a 0.2 mL/min. 
Mobile phases were 0.1 % formic acid in water (A) and 0.1 % formic acid in 
acetonitrile (B). For gradient elution, the initial combination was 30 : 70 (A : B, 
v/v) and the B solution was increased to 100 % in duration of 2 min, holding 












Total P450 Omura and sato 350 pmol/mg 
OR** Cytochrome c Reductase 270 
Cyt. b5 Spectrophotometric 520 pmol/mg 
CYP1A2 Phenacetin O-deethylase 690 
CYP2A6 Coumarin 7-hydroxylase 830 
CYP2B5 (S)-Mephenytoin N-demethylase 40 
CYP2C8 Paclitaxel 6α-hydroxylase 170 
CYP2C9 Diclofenac-4’-hydroxylase 3100 
CYP2C19 (S)-Mephenytoin N-hydroxylase 57 
CYP2D6 Bufuralol 1’-hydroxylase 
(The amount of activity inhibited 
by 1 µM quinidine) 
71 
CYP2E1 Chlorozoxazone 6-hydroxylase 2400 
CYP3A4 Testosterone 6β-hydroxylase 4600 
CYP4A11 Lauric acid 12-hydroxylase 1700 
FMO Methyl p-Tolyl Sulfide Oxidase 1100 
UGT1A1 Estradiol 3-Glucuronidation 940 
UGT1A4 Trifluoperazine Glucuronidation 580 
UGT1A6 Serotonin Glucuronidation 10000 
UGT1A9 Propofol Glucuronidation 3700 
UGT2B7 AZT Glucuronidation 760 
* : Provided from BD Biosciences 




Metabolism of kresoxim-methyl in HLMs (Phase I reaction) 
To determine the metabolite formation from kresoxim-methyl, the incubation 
mixtures containing 50 mM potassium phosphate buffer (pH 7.4), 10 mM 
magnesium chloride, pooled HLMs (0.5 mg/mL), NADPH-generating system 
(1 mM NADP+, 5 mM glucose-6-phosphate, 0.25 U glucose-6-phosphate 
dehydrogenase, and 1 mM NADPH), and 10 μM kresoxim-methyl were 
prepared in a total incubation volume of 200 μL. The reaction mixtures were 
incubated at 37°C for 0, 30, 60, and 120 min in a shaking water bath before 
terminating the reaction by the addition of 200 μL of acetonitrile on ice. The 
reaction mixture was centrifuged at 13,000 rpm for 7 min at 4°C, and the 10 μL 
of supernatant was subsequently analyzed with HPLC. Control incubations 
were conducted in the absence of an NADPH-generating system or with the 
denatured HLMs at 80°C. HLMs were heated for 30 min at 45°C before the 
incubation to confirm whether FMOs are involved in the metabolite formation 
or not.  
 
Metabolite identification 
The acetonitrile supernatant (200 μL) of the pooled HLMs reaction mixture was 
dried with the gentle nitrogen stream, and the residue was dissolved with a 50 
μL of acetonitrile to be analyzed with LC-MS/MS scan mode. 
 
Optimization of metabolic conditions and kinetic studies 
The metabolic reactions were performed with various concentrations of HLMs 
(0.1, 0.2, 0.3, 0.4, and 0.5 mg/mL) for 0, 5, 10, 15, 20, and 30 min in the same 
manner as the above method to determine the optimal reaction conditions.  
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To analyze enzyme kinetics such as Vmax, Km, and CLint, a range of kresoxim-
methyl concentrations (5, 10, 20, 50, 100, and 200 μM) were used in metabolic 
reactions under the optimized conditions (HLMs concentration of 0.2 mg/mL 
and an incubation time of 10 min).  
 
Metabolism of kresoxim-methyl by cDNA-expressed CYP450 isoforms 
The metabolic reactions were performed with ten types of cDNA-expressed 
CYP450 isoforms (10 pmol) and 10 μM of kresoxim-methyl for 10 min to 
identify CYP isoforms responsible for metabolite formation. 
 
Determination of crystal structure  
Small clear crystals were obtained by slow evaporation in a mixture of acetone 
and hexane. The structure of kresoxim-methyl was determined by single crystal 
X-ray diffraction methods by Professor Hoseop Yun group of Ajou University. 





Results and Discussion 
Formation of the kresoxim-methyl metabolite by HLMs 
HLMs incubation of kresoxim-methyl in the presence of NADPH resulted in 
the formation of two metabolite (Fig. 9). No metabolites were observed in 
control reactions with denatured HLMs or with the absence of the NADPH 
generating system, suggesting that metabolites were formed from kresoxim-
methyl by the HLMs metabolic reaction. The metabolites, M1 and M2 from 
HLMs incubation gave [M+H]+ at m/z 330 and [M+H]+ at m/z 312. Judging 
from molecular weight and mass fragment pattern, M1 must be hydroxyl-KM. 
consequentially, the formation of M1 from kresoxim-methyl is resulted in the 
metabolic reaction by CYPs, resulting in oxidation.  
 
Optimization of metabolic conditions and kinetic studies 
A range of HLMs protein concentrations and incubation time were used in 
metabolic reactions to obtain 0.2 mg/mL of protein and 10 min of incubation 
time as the optimal metabolic conditions of kresoxim-methyl in HLMs (Fig. 
11). Under these optimized metabolic conditions, the formation pattern of M1 
from kresoxim-methyl by HLMs was best fitted to a Michaelis-Menten 
equation [V = Vmax × [S] / (Km + [S])] to yield 16.8 counts/min/mg proteins 
of Vmax and 10.2 μM of Km values. M2 In endosulfan sulfate formation from 
α-endosulfan and β-endosulfan by HLMs, Vmax were 1.48 ± 0.07, 4.40 ± 0.18 
pmol/min/ pmol P450, respectively while Km were 7.34 ± 1.29 μM, 6.37 ± 0.88 
μM, respectively (Lee et al. 2006). The Clint (mL/min/ mg proteins) is a pure 
measure of enzyme activity towards a compound and acts as a proportionality 
constant to describe the relationship between rate of metabolism of a drug and 
its concentration at the enzyme site. It is not influenced by other physiological 
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determinants of liver clearance such as hepatic blood flow or drug binding 
within the blood matrix (Rane et al., 1977; Wilkinson, 1987; Houston, 
1994).In this study, the CLint value of M1 was 1.64 μL/min/mg proteins for 
cyazofamid, while those of the other studies was 48.02~51.20 μL/min/mg 
proteins for erythro, threo-flucetosulfuron (Lee et al. 2014). 
 
Metabolism of kresoxim-methyl in cDNA-expressed CYP450 isoforms 
When metabolites formation from kresoxim-methyl was studied with 10 
different human cDNA-expressed CYP isoforms (CYP 1A2, 2A6, 2B6, 2C8, 
2C9, 2C19, 2D6, 2E1, 3A4 and 3A5). The cDNA-expressed CYP isoforms 
were pre-incubated for 5 minutes at 37℃ in the presence of the NADPH-
generating system. The formation of M1 was observed in CYP1A2, 2B6, 2C8, 
2C9, 2C19, 2D6, 3A4, and 3A5 (Fig. 12). The formation of M2 was observed 
only in CYP1A2, 2C8, 2C9, 2C19, 3A4, and 3A5 (Fig. 12). In 63 pesticide 
metabolism studies using human recombinant cytochrome P450 isoforms, CYP 
2C19 was involved in metabolism by 15%, CYP2B6 by 12%, CYP2C9 by 10%, 

















Figure 9. Formation of metabolite M1 and M2 from kresoxim-methyl when 
it was incubated with human liver microsomes and NADPH-generating 







































Figure 10. LC-MS/MS product ion mass spectrum of M1 from kresoxim-
methyl by metabolism of HLM with NADPH-generation system. 
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Figure 11. Formation of metabolites from kresoxim-methyl depending on 


















































Figure 12. The formation of metabolites from kresoxim-methyl by cDNA-
expressed P450 isoforms when those were incubated with 10 μM of 

































Determination of crystal structure for kresoxim-methyl 
An ORTEP diagram and the packing mode for kresoxim-methyl shown 
in Fig. 13. The structure of the title compound were determined by single 
crystal X-ray diffraction methods. A summary of the crystallographic data, 
data collection and structure refinement for the kresoxim-methyl is given in 
Table 27. Preliminary examination and data collection were performed 
with Mo Kα1 radiation (λ=0.71073 Å) on a RIGAKU R-ASXIS RAPID 
diffractometer. The cell constants and an orientation matrix were 
determined from least-squares, using the setting angles in the range 3.0˚< 
θ <25.0˚. Intensity data were collected with the ω scan technique. The 
intensity statistics and systematic absences are consistent with the 
monoclinic space group, C2/c. The initial positions for all atoms were 
obtained by using direct methods of the SHELXS-86 program. The 
structure was refined by full-matrix least-squares techniques with the use 
of the SHELXL-97 program. The data were corrected for absorption 
using the multi-scan method. The final cycle of refinement performed on 
Fo2 with 2914 unique reflections afforded residuals wR2=0.1698 and the 
conventional R index based on the reflections having Fo2 >2σ (Fo2) is 
0.0484. A difference Fourier synthesis calculated with phases based on 
the final parameters shows no peak heights greater than 0.327 e/Å3. No 
unusual trends were found in the goodness of fit as a function of Fo, 
sinθ/λ and Miller indices. Anisotropic displacement parameters and 
complete tabulations on the X-ray studies can be found in CIF format in 




Table 27. Crystal data and structure refinement for kresoxim-methyl 
Empirical formula C18H19NO4 
Formula weight 313.34 
Temperature (K) 293(2) 
Wavelength (Å) 0.71073 
Crystal system Monoclinic 
Space group C2/c 
Unit cell dimensions 
(a, b, c (Å), α, β, γ (°)) 
a = 16.9569(10), b = 15.5663(8), c = 
13.7592(8) 
α = 90, β = 114.461(2), γ = 90 
Volume (Å3) 3305.8(3) 
Z 8 
Calculated density (Mg/m3) 1.259 
Absorption coefficient (mm-1) 0.089 
F(000) 1328 
θ range for data collection (°) 3.08 to 25.00 
Limiting indices -20 ≤ h ≤20, -18 ≤ k ≤18, -16 ≤ l ≤14 
Reflections collected / unique 12796 / 2914 [R(int) = 0.0319] 
Completeness to θ = 25.00 (%) 99.8 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2914 / 0 / 285 
Goodness-of-fit on F2 1.102 
Final R indices [I > 2σ(I)] R1 = 0.0484, wR2 = 0.1296 
R indices (all data) R1 = 0.0887, wR2 = 0.1698 
Extinction coefficient 0.0019(6) 
Largest diff. peak and hole 















Figure 13. ORTEP diagram and numbering scheme (A) and packing 
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Table S1. During mixing/loading hand exposure amount (mg) 
Trials 













1  0.205  0.031  29.201  0.910  0.210  0.036  
2  0.363  0.246  0.361  2.620  0.219  0.052  
3  0.125  0.154  0.295  0.735  0.099  0.067  
4  0.111  0.138  0.166  0.387  0.067  0.065  
5  0.129  0.060  0.251  2.800  0.105  0.113  
6  0.254  0.125  0.016  3.243  0.543  0.109  
7  0.978  0.112  0.033  1.823  0.165  0.995  
8  3.063  0.108  0.046  0.525  0.248  0.778  

















10  2.028  0.855  0.100  1.643  0.127  0.581  
11  5.282  0.984  11.400  3.328  0.237  0.321  
12  3.253  1.072  84.792  6.953  0.045  0.642  
13  1.533  0.689  0.025  1.407  0.212  0.434  
14  0.115  1.229  104.287  1.865  0.069  2.948  
15  0.213  1.229  40.832  4.930  0.400  1.181  
16  0.117  0.345  13.848  2.239  0.097  0.038  
17  0.144  0.124  54.934  24.183  0.088  0.084  
18  2.639  0.261  0.019  2.582  0.410  0.445  
19  0.726  0.318  0.035  1.451  0.887  1.257  

















21  3.682  2.427  224.538  6.584  1.132  1.383  
22  2.022  1.345  20.837  1.607  0.340  1.085  
23  3.145  0.492  51.831  0.901  0.066  0.152  
24  4.126  0.517  0.261  3.629  0.033  0.211  
25  0.075  0.696  0.034  6.527  0.223  0.633  
26  0.358  1.420  0.404  8.001  0.038  0.167  
27  0.494  0.377  0.039  10.304  0.328  0.249  
28  0.962  0.167  0.024  5.134  0.203  1.196  
29  2.068  0.346  34.968  2.933  0.109  0.240  




Table S2. During mixing/loading, ratio of exposure (%) 
Trials 













1  0.00164  0.00025  0.00091  0.01168  0.00053  0.00002  
2  0.00290  0.00197  0.00262  0.00014  0.00055  0.00003  
3  0.00100  0.00123  0.00073  0.00012  0.00025  0.00004  
4  0.00089  0.00110  0.00039  0.00007  0.00017  0.00004  
5  0.00103  0.00048  0.00280  0.00010  0.00026  0.00007  
6  0.00203  0.00100  0.00324  0.00001  0.00136  0.00007  
7  0.00782  0.00089  0.00182  0.00001  0.00041  0.00063  
8  0.02450  0.00087  0.00053  0.00002  0.00062  0.00049  
9  0.01144  0.00928  0.00174  0.01322  0.00066  0.00140  
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10  0.01622  0.00684  0.00164  0.00004  0.00032  0.00037  
11  0.04226  0.00787  0.00333  0.00456  0.00059  0.00020  
12  0.02603  0.00857  0.00695  0.03392  0.00011  0.00041  
13  0.01226  0.00551  0.00141  0.00001  0.00053  0.00028  
14  0.00092  0.00983  0.00186  0.04171  0.00017  0.00187  
15  0.00170  0.00983  0.00493  0.01633  0.00100  0.00075  
16  0.00094  0.00276  0.00224  0.00554  0.00024  0.00002  
17  0.00115  0.00100  0.02418  0.02197  0.00022  0.00005  
18  0.02111  0.00209  0.00258  0.00001  0.00102  0.00028  
19  0.00581  0.00254  0.00145  0.00001  0.00222  0.00080  
20  0.02474  0.00603  0.00182  0.00005  0.00042  0.00005  
21  0.02946  0.01941  0.00658  0.08982  0.00283  0.00088  
22  0.01618  0.01076  0.00161  0.00833  0.00085  0.00069  
23  0.02516  0.00394  0.00090  0.02073  0.00016  0.00010  
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24  0.03301  0.00414  0.00363  0.00010  0.00008  0.00013  
25  0.00060  0.00557  0.00653  0.00001  0.00056  0.00040  
26  0.00286  0.01136  0.00800  0.00016  0.00010  0.00011  
27  0.00395  0.00302  0.01030  0.00002  0.00082  0.00016  
28  0.00769  0.00134  0.00513  0.00001  0.00051  0.00076  
29  0.01654  0.00277  0.00293  0.01399  0.00027  0.00015  






Table S3. During mixing/loading, hand exposure volume (mL)  
Trials 













1  4.1  0.6  4.5  58.4  5.3  0.2  
2  7.3  4.9  13.1  0.7  5.5  0.3  
3  2.5  3.1  3.7  0.6  2.5  0.4  
4  2.2  2.8  1.9  0.3  1.7  0.4  
5  2.6  1.2  14.0  0.5  2.6  0.7  
6  5.1  2.5  16.2  0.0  13.6  0.7  
7  19.6  2.2  9.1  0.1  4.1  6.3  
8  61.3  2.2  2.6  0.1  6.2  4.9  

















10  40.6  17.1  8.2  0.2  3.2  3.7  
11  105.6  19.7  16.6  22.8  5.9  2.0  
12  65.1  21.4  34.8  169.6  1.1  4.1  
13  30.7  13.8  7.0  0.0  5.3  2.8  
14  2.3  24.6  9.3  208.6  1.7  18.7  
15  4.3  24.6  24.6  81.7  10.0  7.5  
16  2.3  6.9  11.2  27.7  2.4  0.2  
17  2.9  2.5  120.9  109.9  2.2  0.5  
18  52.8  5.2  12.9  0.0  10.2  2.8  
19  14.5  6.4  7.3  0.1  22.2  8.0  

















21  73.6  48.5  32.9  449.1  28.3  8.8  
22  40.4  26.9  8.0  41.7  8.5  6.9  
23  62.9  9.8  4.5  103.7  1.6  1.0  
24  82.5  10.3  18.1  0.5  0.8  1.3  
25  1.5  13.9  32.6  0.1  5.6  4.0  
26  7.2  28.4  40.0  0.8  1.0  1.1  
27  9.9  7.5  51.5  0.1  8.2  1.6  
28  19.2  3.3  25.7  0.0  5.1  7.6  
29  41.4  6.9  14.7  69.9  2.7  1.5  





Table S4. During mixing/loading, hand exposure amount per active ingredient (mg/kg a.i) 
Trials 













1  16.44  2.51  116.80  9.10  5.26  0.14  
2  58.48  19.69  1.44  26.20  0.88  0.21  
3  20.11  12.31  1.18  7.35  0.40  0.27  
4  17.90  11.02  0.67  3.87  0.27  0.26  
5  20.82  4.78  1.00  28.00  0.42  0.45  
6  40.99  10.04  0.06  32.43  2.17  0.44  
7  157.69  8.92  0.13  18.23  0.66  3.98  
8  494.04  8.65  0.18  5.25  0.99  3.11  

















10  327.11  68.43  0.40  16.43  0.51  2.32  
11  851.96  78.72  45.60  33.28  0.95  1.29  
12  524.75  85.73  339.17  69.53  0.18  2.57  
13  247.21  55.08  0.10  14.07  0.85  1.74  
14  18.51  98.32  417.15  18.65  0.27  11.79  
15  34.30  98.32  163.33  49.30  1.60  4.72  
16  18.94  27.63  55.39  22.39  0.39  0.15  
17  23.24  9.95  219.74  241.83  0.35  0.34  
18  425.60  20.85  0.08  25.82  1.64  1.78  

















20  498.86  60.33  0.51  18.24  0.67  0.33  
21  593.95  194.14  898.15  65.84  4.53  5.53  
22  326.18  107.60  83.35  16.07  1.36  4.34  
23  507.22  39.40  207.32  9.01  0.26  0.61  
24  665.45  41.38  1.05  36.29  0.13  0.84  
25  12.12  55.65  0.13  65.27  0.89  2.53  
26  57.76  113.60  1.62  80.01  0.15  0.67  
27  79.70  30.19  0.16  103.04  1.31  1.00  
28  155.12  13.39  0.10  51.34  0.81  4.78  
29  333.50  27.70  139.87  29.33  0.44  0.96  
30  471.15  82.30  0.16  26.18  0.40  7.48  
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Sum 7,346.86 1,504.9 2,827.22 1,154.24 33.35 78.46 
Average 244.9  50.2  94.24  38.48  1.11  2.62  
75percentile 459.8  81.4  128.38  46.04  1.25  4.25  
Minimum 12.1  2.5  0.06  3.87  0.13  0.14  





Table S5. During mixing/loading, inhalation exposure amount (mg)  
Trials 









1  <LOQ <LOQ <LOQ <LOQ 
2  <LOQ 0.004  <LOQ <LOQ 
3  <LOQ <LOQ 2.807  <LOQ 
4  <LOQ 0.004  <LOQ <LOQ 
5  <LOQ <LOQ <LOQ <LOQ 
6  0.026  <LOQ <LOQ <LOQ 
7  0.001  <LOQ <LOQ <LOQ 
8  <LOQ 0.006  <LOQ <LOQ 
9  0.003  0.001  <LOQ <LOQ 
10  <LOQ 0.008  <LOQ <LOQ 
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11  0.005  0.007  <LOQ <LOQ 
12  0.016  0.010  <LOQ <LOQ 
13  0.007  <LOQ <LOQ <LOQ 
14  <LOQ 0.009  <LOQ <LOQ 
15  0.018  <LOQ <LOQ <LOQ 
16  <LOQ 0.004  <LOQ <LOQ 
17  <LOQ 0.092  <LOQ <LOQ 
18  0.005  0.000  0.003  0.003  
19  0.003  0.039  <LOQ <LOQ 
20  0.008  0.024  <LOQ <LOQ 
21  0.004  0.020  <LOQ <LOQ 
22  0.011  0.007  0.002  0.002  
23  0.016  0.006  <LOQ <LOQ 
24  0.018  0.003  0.003  0.003  
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25  0.006  0.010  <LOQ <LOQ 
26  0.006  0.008  <LOQ <LOQ 
27  0.030  0.016  <LOQ <LOQ 
28  0.012  0.019  <LOQ <LOQ 
29  <LOQ <LOQ <LOQ <LOQ 
30  0.004  <LOQ <LOQ <LOQ 
Average 0.01 0.01 0.70 0.00 





Table S6. During mixing/loading, ratio to inhalation exposure (%)  
Trials 









1  N.D N.D N.D N.D 
2  N.D N.D N.D N.D 
3  N.D N.D 7.02E-06 N.D 
4  5.04E-10 5.04E-10 N.D N.D 
5  2.52E-10 2.52E-10 N.D N.D 
6  2.09E-07 2.09E-07 N.D N.D 
7  1.13E-08 1.13E-08 N.D N.D 
8  N.D N.D N.D N.D 
9  2.44E-08 2.44E-08 N.D N.D 
10  3.02E-09 3.02E-09 N.D N.D 
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11  3.7E-08 3.7E-08 N.D N.D 
12  1.25E-07 1.25E-07 N.D N.D 
13  5.59E-08 5.59E-08 N.D N.D 
14  2.52E-10 2.52E-10 N.D N.D 
15  1.45E-07 1.45E-07 N.D N.D 
16  N.D N.D N.D N.D 
17  N.D N.D N.D N.D 
18  3.78E-08 3.78E-08 N.D 1.76E-09 
19  2.49E-08 2.49E-08 N.D N.D 
20  6.07E-08 6.07E-08 N.D N.D 
21  3.02E-08 3.02E-08 N.D N.D 
22  8.74E-08 8.74E-08 N.D 1.03E-09 
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23  1.25E-07 1.25E-07 N.D N.D 
24  1.4E-07 1.4E-07 N.D 2.12E-09 
25  4.43E-08 4.43E-08 N.D N.D 
26  4.96E-08 4.96E-08 N.D N.D 
27  2.36E-07 2.36E-07 N.D N.D 
28  9.25E-08 9.25E-08 N.D N.D 
29  N.D N.D N.D N.D 
30  3.2E-08 3.2E-08 N.D N.D 









Table S7. During mixing/loading, hand exposure amount per active ingredient (mg/kg a.i) 
Trials 









1  N.D N.D N.D N.D 
2  N.D 0.000017  N.D  N.D 
3  N.D 0.000001  0.011226  N.D 
4  N.D 0.000015  N.D N.D 
5  N.D 0.000002  N.D N.D 
6  0.000104  N.D N.D N.D 
7  0.000006  N.D N.D N.D 
8  N.D 0.000024  N.D N.D 
9  0.000012  0.000003  N.D N.D 
10  0.000002  0.000030  N.D N.D 
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11  0.000019  0.000030  N.D N.D 
12  0.000063  0.000041  N.D N.D 
13  0.000028  N.D  N.D N.D 
14  N.D  0.000035  N.D N.D 
15  0.000073  N.D N.D N.D 
16  N.D 0.000015  N.D N.D 
17  N.D 0.000369  N.D N.D 
18  0.000019  N.D N.D 0.000011  
19  0.000012  0.000158  N.D N.D 
20  0.000030  0.000098  N.D N.D 
21  0.000015  0.000080  N.D N.D 
22  0.000044  0.000026  N.D 0.000006  
168 
 
23  0.000062  0.000023  N.D N.D 
24  0.000070  0.000011  N.D 0.000013  
25  0.000022  0.000041  N.D N.D 
26  0.000025  0.000032  N.D N.D 
27  0.000118  0.000066  N.D N.D 
28  0.000046  0.000076  N.D N.D 
29  N.D N.D N.D N.D 
30  0.000016  N.D N.D N.D 
Sum 0.000786 0.001193 0.011226 0.00003 
Average 0.000026  0.000040  0.000374  0.000001  
75percentile 0.000040  0.000039  N.D N.D 
Minimum 12.1  2.5  0.13  0.14  
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Abstract in Korean 
다양한 노출 경로 및 노출 상황에 대한 농작업자의 노출의 정량적 
평가는 농약의 합리적 농약의 안전성과 위해성 평가를 가능하게 
한다. 그러나 다종의 농약과 다양한 농작업에 해당하는 노출량을 
모두 측정하기는 현실적으로 어렵다. 이에 따라 유럽 및 미국 등 
다른 나라의 경우 자국에 맞는 대표경우를 선발, 다년간 반복 포장 
노출 실험결과를 토대로 노출량 예측 모델을 개발하고 이를 
이용하여 농약 노출량을 예측, 평가하고 있다. 현재 우리나라는 
UK-POEM 을 이용하여 농약의 노출량을 예측 평가하고 있다. 
하지만 이는 유럽의 농약의 사용 양상, 농업 및 농작업 형태를 
반영하여 개발된 것이라서 모델들 간에도 노출요소의 여러 면에서 
서로 차이가 있는 문제점을 갖고 있다. 본 연구자는 우리나라 
농약의 종류 및 사용 양상과 농작업 및 농업 형태에 적합한 
노출요소를 포함한 ‘한국형 농약노출량 예측모델’을 개발 연구를 
수행하였다. 대표 작물로 벼, 사과를 선정하였으며 각 농업형태에 
맞는 살포기기인 SS 기와 PS 기를 사용하였고 농약 제형은 유제, 
수화제, 입상수화제를 사용하였다. 살포액 조제 및 살포 시 노출 
시나리오로 패치법을 이용한 피부 노출 및 XAD-2 레진을 이용한 
호흡 노출량을 측정하였다. 또한 검출한계, 정량한계, 회수율, 
재현성, 검량선의 직선성, 포집효율, 파과시험의 분석법 검증을 통해 
노출 시험 수행에 적합한 합리적인 결과를 얻었다. 이에 따라 
시나리오에 따른 농약 살포액 조제 및 살포 시 75 백분위수 
노출량을 산출하여 한국형 모델의 노출요소로 도출하였다. 도출된 
노출량을 토대로 위해성 평가를 실시하여 농작업자의 위해성 
여부를 확인한 결과 위해성을 나타내는 MOS값이 1보다 큰 값으로 
위해 가능성이 적은 것으로 나타났다. kresoxim-methyl 의 
크리스탈 구조를 확인하고 인간 간 마이크로좀에 의한 대사연구를 
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통하여 대사 양상과 대사물을 확인하였고 rCYPs 2A6 와 rCYPs 
2E1을 제외한 8종의 rCYPs가 대사물을 생성함을 확인하였다.   
주요어: 농작업자 노출, 대사, 농작업자 모델, 위해성평가, 피부노출, 
호흡노출 
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